GRK2
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A0MZ66 | S473 | Sugiyama | SHTN1 KIAA1598 | LGtLNKSTSSRsLKsLDPENsEtELERILRRRKVtAEADss |
| A0MZ66 | S586 | Sugiyama | SHTN1 KIAA1598 | RKKYIDGEKQAEPVVVLDPVsTHEPQTKDQVAEKDPTQHKE |
| A5A3E0 | S1068 | Sugiyama | POTEF A26C1B | SLSTFQQMWISKQEyDEsGPsIVHRKCL_____________ |
| O00170 | T48 | Sugiyama | AIP XAP2 | FQDGTKATFHYRtLHsDDEGtVLDDsRARGKPMELIIGKKF |
| O00505 | S60 | Sugiyama | KPNA3 QIP2 | KRDEHLLKKRNVPQEEsLEDsDVDADFKAQNVTLEAILQNA |
| O00592 | T556 | Sugiyama | PODXL PCLP PCLP1 | DsWIVPLDNLTKDDLDEEEDtHL__________________ |
| O00629 | S60 | Sugiyama | KPNA4 QIP1 | KRDEHLLKRRNVPHEDICEDsDIDGDYRVQNtsLEAIVQNA |
| O14980 | S1031 | Sugiyama | XPO1 CRM1 | FKEHLRDFLVQIKEFAGEDtsDLFLEEREIALRQADEEKHK |
| O43423 | S100 | Sugiyama | ANP32CP PP32R1 | AEKCPNLTHLYLSGNKIKDLstIEPLKQLENLKSLDLFNCE |
| O43615 | S94 | Sugiyama | TIMM44 MIMT44 TIM44 | NKEMKESIKKFRDEARRLEEsDVLQEARRKyKtIESETVRT |
| O43823 | T681 | Sugiyama | AKAP8 AKAP95 | ESAQTRVAPAPAAADAEVEQtDAEsKDAVPTE_________ |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O60220 | S96 | Sugiyama | TIMM8A DDP DDP1 TIM8A | FILNRLEQTQKSKPVFSEsLsD___________________ |
| O60353 | S648 | PSP | FZD6 | LsGEQVDGKGQAGsVSESARsEGRIsPKsDItDtGLAQSNN |
| O60573 | S13 | Sugiyama | EIF4E2 EIF4EL3 | ________MNNKFDALKDDDsGDHDQNEENSTQKDGEKEKT |
| O60716 | S252 | Sugiyama | CTNND1 KIAA0384 | sRVtRIEERyRPsMEGyRAPsRQDVyGPQPQVRVGGssVDL |
| O75410 | S44 | Sugiyama | TACC1 KIAA1103 | GGAAGEDEAGGPEGDPEEEDsQAETKsLsFssDsEGNFETP |
| O76070 | S124 | GPS6|SIGNOR|EPSD | SNCG BCSG1 PERSYN PRSN | APQQEGEAsKEKEEVAEEAQsGGD_________________ |
| O95218 | S120 | Sugiyama | ZRANB2 ZIS ZNF265 | tGYGGGFNERENVEyIEREEsDGEyDEFGRKKKKYRGKAVG |
| O95626 | S104 | Sugiyama | ANP32D PP32R2 | AEKCPNLIHLNLSGNKIKDLstIEPLKKLENLESLDLFTCE |
| O95757 | S508 | Sugiyama | HSPA4L APG1 HSPH3 OSP94 | GIFSVASASVIEKQNLEGDHsDAPMETEtsFKNENKDNMDK |
| O95816 | S208 | Sugiyama | BAG2 | IKLLEHSKGAGSKTLQQNAEsRFN_________________ |
| P04075 | S17 | Sugiyama | ALDOA ALDA | ____MPyQyPALtPEQKKELsDIAHRIVAPGKGILAADEst |
| P04075 | S336 | Sugiyama | ALDOA ALDA | GKKENLKAAQEEYVKRALANsLACQGKytPsGQAGAAAsEs |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04083 | S201 | Sugiyama | ANXA1 ANX1 LPC1 | LsLAKGDRsEDFGVNEDLADsDARALyEAGERRKGtDVNVF |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04637 | T55 | PSP | TP53 P53 | LPsQAMDDLMLsPDDIEQWFtEDPGPDEAPRMPEAAPPVAP |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05187 | S434 | Sugiyama | ALPP PLAP | LYGNGPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDEETH |
| P05187 | S436 | Sugiyama | ALPP PLAP | GNGPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDEETHAG |
| P05386 | S101 | Sugiyama | RPLP1 RRP1 | APstAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD_______ |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S102 | GPS6|SIGNOR|ELM|EPSD|Sugiyama | RPLP2 D11S2243E RPP2 | PAAGsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD_______ |
| P05387 | S105 | GPS6|SIGNOR|ELM|EPSD|Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05556 | S509 | Sugiyama | ITGB1 FNRB MDF2 MSK12 | CRCNEGRVGRHCECstDEVNsEDMDAYCRKENSSEICSNNG |
| P05556 | S689 | Sugiyama | ITGB1 FNRB MDF2 MSK12 | NITKVEsRDKLPQPVQPDPVsHCKEKDVDDCWFYFTYSVNG |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07237 | S427 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | WDKLGEtyKDHENIVIAKMDstANEVEAVKVHsFPtLKFFP |
| P07237 | S88 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | GKLKAEGSEIRLAKVDAtEEsDLAQQyGVRGyPtIKFFRNG |
| P07355 | S184 | Sugiyama | ANXA2 ANX2 ANX2L4 CAL1H LPC2D | sGDFRKLMVALAKGRRAEDGsVIDyELIDQDARDLyDAGVK |
| P07437 | S115 | Sugiyama | TUBB TUBB5 OK/SW-cl.56 | sGAGNNWAKGHytEGAELVDsVLDVVRKEAESCDCLQGFQL |
| P07550 | S355 | ELM|EPSD|PSP | ADRB2 ADRB2R B2AR | AFQELLCLRRssLKAyGNGyssNGNtGEQsGYHVEQEKENK |
| P07550 | S356 | ELM|EPSD|PSP | ADRB2 ADRB2R B2AR | FQELLCLRRssLKAyGNGyssNGNtGEQsGYHVEQEKENKL |
| P07550 | S396 | GPS6|ELM|EPSD|PSP | ADRB2 ADRB2R B2AR | LLCEDLPGtEDFVGHQGtVPsDNIDsQGRNCstNDsLL___ |
| P07550 | S401 | GPS6|ELM|EPSD|PSP | ADRB2 ADRB2R B2AR | LPGtEDFVGHQGtVPsDNIDsQGRNCstNDsLL________ |
| P07550 | S407 | GPS6|ELM|EPSD|PSP | ADRB2 ADRB2R B2AR | FVGHQGtVPsDNIDsQGRNCstNDsLL______________ |
| P07550 | S411 | EPSD|PSP | ADRB2 ADRB2R B2AR | QGtVPsDNIDsQGRNCstNDsLL__________________ |
| P07550 | T384 | GPS6|ELM|EPSD|PSP | ADRB2 ADRB2R B2AR | sGYHVEQEKENKLLCEDLPGtEDFVGHQGtVPsDNIDsQGR |
| P07737 | S30 | Sugiyama | PFN1 | NLMADGTCQDAAIVGYKDsPsVWAAVPGKtFVNITPAEVGV |
| P07814 | S739 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | TKVEATKNETSAPFKERPtPsLNNNCttsEDsLVLyNRVAV |
| P07814 | T746 | Sugiyama | EPRS1 EPRS GLNS PARS QARS QPRS PIG32 | NETSAPFKERPtPsLNNNCttsEDsLVLyNRVAVQGDVVRE |
| P07900 | S50 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | MSLIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKL |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | S641 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DNstMGyMAAKKHLEINPDHsIIEtLRQKAEADKNDKSVKD |
| P07900 | T195 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | DTGEPMGRGTKVILHLKEDQtEyLEERRIKEIVKKHSQFIG |
| P07900 | T305 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IDQEELNKtKPIWtRNPDDItNEEyGEFyKsLtNDWEDHLA |
| P08069 | S1278 | SIGNOR|EPSD|PSP | IGF1R | SFLEIISSIKEEMEPGFREVsFyySEENKLPEPEELDLEPE |
| P08172 | S232 | ELM|EPSD|PSP | CHRM2 | ASKSRIKKDKKEPVANQDPVsPsLVQGRIVKPNNNNMPssD |
| P08172 | S234 | ELM|EPSD|PSP | CHRM2 | KSRIKKDKKEPVANQDPVsPsLVQGRIVKPNNNNMPssDDG |
| P08172 | S250 | ELM|EPSD|PSP | CHRM2 | PVsPsLVQGRIVKPNNNNMPssDDGLEHNKIQNGKAPRDPV |
| P08172 | S251 | ELM|EPSD|PSP | CHRM2 | VsPsLVQGRIVKPNNNNMPssDDGLEHNKIQNGKAPRDPVt |
| P08172 | S282 | ELM|EPSD|PSP | CHRM2 | NGKAPRDPVtENCVQGEEKEssNDstsVsAVAsNMRDDEIt |
| P08172 | S283 | ELM|EPSD|PSP | CHRM2 | GKAPRDPVtENCVQGEEKEssNDstsVsAVAsNMRDDEItQ |
| P08172 | S286 | ELM|EPSD|PSP | CHRM2 | PRDPVtENCVQGEEKEssNDstsVsAVAsNMRDDEItQDEN |
| P08172 | S288 | ELM|EPSD|PSP | CHRM2 | DPVtENCVQGEEKEssNDstsVsAVAsNMRDDEItQDENtV |
| P08172 | S290 | ELM|EPSD|PSP | CHRM2 | VtENCVQGEEKEssNDstsVsAVAsNMRDDEItQDENtVst |
| P08172 | S294 | ELM|EPSD|PSP | CHRM2 | CVQGEEKEssNDstsVsAVAsNMRDDEItQDENtVstsLGH |
| P08172 | S309 | ELM|EPSD|PSP | CHRM2 | VsAVAsNMRDDEItQDENtVstsLGHSKDENSKQTCIRIGT |
| P08172 | S311 | ELM|EPSD|PSP | CHRM2 | AVAsNMRDDEItQDENtVstsLGHSKDENSKQTCIRIGTKT |
| P08172 | T271 | ELM|EPSD|PSP | CHRM2 | sDDGLEHNKIQNGKAPRDPVtENCVQGEEKEssNDstsVsA |
| P08172 | T287 | ELM|EPSD|PSP | CHRM2 | RDPVtENCVQGEEKEssNDstsVsAVAsNMRDDEItQDENt |
| P08172 | T302 | ELM|EPSD|PSP | CHRM2 | ssNDstsVsAVAsNMRDDEItQDENtVstsLGHSKDENSKQ |
| P08172 | T307 | ELM|EPSD|PSP | CHRM2 | tsVsAVAsNMRDDEItQDENtVstsLGHSKDENSKQTCIRI |
| P08172 | T310 | ELM|EPSD|PSP | CHRM2 | sAVAsNMRDDEItQDENtVstsLGHSKDENSKQTCIRIGTK |
| P08195 | S598 | Sugiyama | SLC3A2 MDU1 | LQASDLPASASLPAKADLLLstQPGREEGsPLELERLKLEP |
| P08238 | S468 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | RRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKsIyyItG |
| P08238 | T190 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| P08670 | S459 | Sugiyama | VIM | KRTLLIKtVEtRDGQVINEtsQHHDDLE_____________ |
| P08708 | S89 | Sugiyama | RPS17 RPS17L | ISIKLQEEERERRDNyVPEVsALDQEIIEVDPDtKEMLKLL |
| P08913 | S311 | SIGNOR | ADRA2A ADRA2R ADRAR | APGEPAPAGPRDTDALDLEEssssDHAERPPGPRRPERGPR |
| P08913 | S312 | SIGNOR | ADRA2A ADRA2R ADRAR | PGEPAPAGPRDTDALDLEEssssDHAERPPGPRRPERGPRG |
| P08913 | S313 | SIGNOR | ADRA2A ADRA2R ADRAR | GEPAPAGPRDTDALDLEEssssDHAERPPGPRRPERGPRGK |
| P08913 | S314 | SIGNOR | ADRA2A ADRA2R ADRAR | EPAPAGPRDTDALDLEEssssDHAERPPGPRRPERGPRGKG |
| P09497 | S205 | SIGNOR|EPSD|PSP | CLTB | EETPGTEWEKVAQLCDFNPKssKQCKDVSRLRsVLMsLKQT |
| P09619 | S1104 | GPS6|ELM|EPSD | PDGFRB PDGFR PDGFR1 | PELEQLPDSGCPAPRAEAEDsFL__________________ |
| P0CG38 | S1068 | Sugiyama | POTEI | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P0CG39 | S1031 | Sugiyama | POTEJ | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P10696 | S431 | Sugiyama | ALPG ALPPL ALPPL2 | LYGNGPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDGETH |
| P10696 | S433 | Sugiyama | ALPG ALPPL ALPPL2 | GNGPGYVLKDGARPDVtEsEsGsPEyRQQSAVPLDGETHAG |
| P11142 | T226 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVNHFIAEFK |
| P12270 | S1838 | Sugiyama | TPR | TVSATPSSSLPKRtREEEEDstIEAsDQVsDDtVEMPLPKK |
| P13489 | S290 | Sugiyama | RNH1 PRI RNH | AKGCGDLCRVLRAKESLKELsLAGNELGDEGARLLCETLLE |
| P13639 | S587 | Sugiyama | EEF2 EF2 | CIPIKKSDPVVsyREtVsEEsNVLCLsKsPNKHNRLyMKAR |
| P13693 | S15 | Sugiyama | TPT1 | ______MIIYRDLIsHDEMFsDIyKIREIADGLCLEVEGKM |
| P13804 | S197 | Sugiyama | ETFA | ATsGGsASsEKAsStsPVEIsEWLDQKLTKSDRPELTGAKV |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14625 | S172 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | VGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSELI |
| P14625 | S306 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | TETVEEPMEEEEAAKEEKEEsDDEAAVEEEEEEKKPKTKKV |
| P15311 | T567 | GPS6|SIGNOR|ELM|EPSD|PSP | EZR VIL2 | RTHNDIIHNENMRQGRDKYKtLRQIRQGNTKQRIDEFEAL_ |
| P17812 | S578 | Sugiyama | CTPS1 CTPS | GCRLsPRDtysDRsGsssPDsEItELKFPsINHD_______ |
| P17812 | T581 | Sugiyama | CTPS1 CTPS | LsPRDtysDRsGsssPDsEItELKFPsINHD__________ |
| P17987 | S551 | Sugiyama | TCP1 CCT1 CCTA | IKLHPESKDDKHGsyEDAVHsGALND_______________ |
| P18545 | T62 | GPS6|SIGNOR|ELM|EPSD | PDE6G PDEG | PPKKGVQGFGDDIPGMEGLGtDITVICPWEAFNHLELHELA |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P19338 | S619 | Sugiyama | NCL | RIVTDRETGssKGFGFVDFNsEEDAKAAKEAMEDGEIDGNK |
| P20042 | T31 | Sugiyama | EIF2S2 EIF2B | tMsKKKKKKKKPFMLDEEGDtQtEEtQPsETKEVEPEPtED |
| P20042 | T33 | Sugiyama | EIF2S2 EIF2B | sKKKKKKKKPFMLDEEGDtQtEEtQPsETKEVEPEPtEDKD |
| P20810 | S373 | Sugiyama | CAST | LPEPEEKPKPRsEsELIDELsEDFDRsECKEKPSKPTEKTE |
| P21462 | S328 | GPS6|SIGNOR|ELM|EPSD | FPR1 | FRERLIHALPASLERALtEDstQtsDtAtNstLPsAEVELQ |
| P21462 | S332 | GPS6|SIGNOR|ELM|EPSD | FPR1 | LIHALPASLERALtEDstQtsDtAtNstLPsAEVELQAK__ |
| P21462 | S338 | GPS6|ELM|EPSD | FPR1 | ASLERALtEDstQtsDtAtNstLPsAEVELQAK________ |
| P21462 | T329 | GPS6|SIGNOR|ELM|EPSD | FPR1 | RERLIHALPASLERALtEDstQtsDtAtNstLPsAEVELQA |
| P21462 | T331 | GPS6|SIGNOR|ELM|EPSD | FPR1 | RLIHALPASLERALtEDstQtsDtAtNstLPsAEVELQAK_ |
| P21462 | T334 | GPS6|SIGNOR|ELM|EPSD | FPR1 | HALPASLERALtEDstQtsDtAtNstLPsAEVELQAK____ |
| P21462 | T336 | GPS6|SIGNOR|ELM|EPSD | FPR1 | LPASLERALtEDstQtsDtAtNstLPsAEVELQAK______ |
| P21462 | T339 | GPS6|SIGNOR|ELM|EPSD | FPR1 | SLERALtEDstQtsDtAtNstLPsAEVELQAK_________ |
| P21731 | S239 | SIGNOR|PSP | TBXA2R | VATLCHVYHGQEAAQQRPRDsEVEMMAQLLGIMVVASVCWL |
| P23396 | S209 | Sugiyama | RPS3 OK/SW-cl.26 | MLPWDPTGKIGPKKPLPDHVsIVEPKDEILPttPIsEQKGG |
| P24752 | T185 | Sugiyama | ACAT1 ACAT MAT | RGSTPYGGVKLEDLIVKDGLtDVyNKIHMGsCAENTAKKLN |
| P25098 | S487 | Sugiyama | GRK2 ADRBK1 BARK BARK1 | PPPLIPPRGEVNAADAFDIGsFDEEDtKGIKLLDsDQELYR |
| P25098 | S501 | Sugiyama | GRK2 ADRBK1 BARK BARK1 | DAFDIGsFDEEDtKGIKLLDsDQELYRNFPLTISERWQQEV |
| P25098 | T493 | Sugiyama | GRK2 ADRBK1 BARK BARK1 | PRGEVNAADAFDIGsFDEEDtKGIKLLDsDQELYRNFPLTI |
| P25100 | S300 | PSP | ADRA1D ADRA1A | VARSTTRSLEAGVKRERGKAsEVVLRIHCRGAATGADGAHG |
| P25100 | S323 | PSP | ADRA1D ADRA1A | VLRIHCRGAATGADGAHGMRsAKGHtFRssLsVRLLKFSRE |
| P25100 | S332 | PSP | ADRA1D ADRA1A | ATGADGAHGMRsAKGHtFRssLsVRLLKFSREKKAAKTLAI |
| P25100 | S334 | PSP | ADRA1D ADRA1A | GADGAHGMRsAKGHtFRssLsVRLLKFSREKKAAKTLAIVV |
| P25100 | S516 | PSP | ADRA1D ADRA1A | EWRLLGPFRRPtTQLRAKVssLsHKIRAGGAQRAEAACAQR |
| P25100 | S518 | PSP | ADRA1D ADRA1A | RLLGPFRRPtTQLRAKVssLsHKIRAGGAQRAEAACAQRSE |
| P25101 | S391 | PSP | EDNRA ETA ETRA | FVSKKFKNCFQsCLCCCCyQsKsLMtsVPMNGtsIQWKNHD |
| P25101 | S393 | PSP | EDNRA ETA ETRA | SKKFKNCFQsCLCCCCyQsKsLMtsVPMNGtsIQWKNHDQN |
| P25101 | S397 | PSP | EDNRA ETA ETRA | KNCFQsCLCCCCyQsKsLMtsVPMNGtsIQWKNHDQNNHNt |
| P25101 | S404 | PSP | EDNRA ETA ETRA | LCCCCyQsKsLMtsVPMNGtsIQWKNHDQNNHNtDRssHKD |
| P25101 | T396 | PSP | EDNRA ETA ETRA | FKNCFQsCLCCCCyQsKsLMtsVPMNGtsIQWKNHDQNNHN |
| P25101 | T403 | PSP | EDNRA ETA ETRA | CLCCCCyQsKsLMtsVPMNGtsIQWKNHDQNNHNtDRssHK |
| P25205 | S711 | Sugiyama | MCM3 | RRKTRQPDAKDGDsyDPyDFsDtEEEMPQVHtPKTADsQEt |
| P25205 | T198 | Sugiyama | MCM3 | DEENNPLETEyGLSVyKDHQtITIQEMPEKAPAGQLPRSVD |
| P25705 | S52 | Sugiyama | ATP5F1A ATP5A ATP5A1 ATP5AL2 ATPM | AARNFHASNTHLQKtGtAEMssILEERILGADtsVDLEETG |
| P25786 | T11 | Sugiyama | PSMA1 HC2 NU PROS30 PSC2 | __________MFRNQyDNDVtVWsPQGRIHQIEYAMEAVKQ |
| P25788 | S250 | Sugiyama | PSMA3 HC8 PSC8 | KDIREEAEKyAKEsLKEEDEsDDDNM_______________ |
| P25788 | S97 | Sugiyama | PSMA3 HC8 PSC8 | AVAGLLADARSLADIAREEAsNFRSNFGyNIPLKHLADRVA |
| P26038 | S576 | Sugiyama | MSN | YKtLRQIRQGNTKQRIDEFEsM___________________ |
| P26038 | T558 | EPSD|PSP | MSN | KTANDMIHAENMRLGRDKYKtLRQIRQGNTKQRIDEFEsM_ |
| P26196 | S475 | Sugiyama | DDX6 HLR2 RCK | TEIKPIPsNIDKSLyVAEyHsEPVEDEKP____________ |
| P26639 | S522 | Sugiyama | TARS1 TARS | PEKFLGDIEVWDQAEKQLENsLNEFGEKWELNsGDGAFyGP |
| P27797 | S189 | Sugiyama | CALR CRTC | THLytLIVRPDNtyEVKIDNsQVEsGsLEDDWDFLPPKKIK |
| P27797 | S214 | Sugiyama | CALR CRTC | GsLEDDWDFLPPKKIKDPDAsKPEDWDERAKIDDPtDsKPE |
| P27816 | S643 | Sugiyama | MAP4 | IsPEtVTGtGKKCsLPAEEDsVLEKLGERKPCNsQPSELSS |
| P29401 | S295 | Sugiyama | TKT | ysQIQsKKKILAtPPQEDAPsVDIANIRMPsLPsyKVGDKI |
| P30041 | S186 | Sugiyama | PRDX6 AOP2 KIAA0106 | SLQLTAEKRVAtPVDWKDGDsVMVLPtIPEEEAKKLFPKGV |
| P30050 | S138 | Sugiyama | RPL12 | HRSLARELsGtIKEILGtAQsVGCNVDGRHPHDIIDDINsG |
| P30050 | S157 | Sugiyama | RPL12 | QsVGCNVDGRHPHDIIDDINsGAVECPAs____________ |
| P30101 | S474 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | yFsPANKKLNPKKyEGGRELsDFIsyLQREAtNPPVIQEEK |
| P30101 | T485 | Sugiyama | PDIA3 ERP57 ERP60 GRP58 | KKyEGGRELsDFIsyLQREAtNPPVIQEEKPKKKKKAQEDL |
| P30411 | S366 | SIGNOR | BDKRB2 BKR2 | VyQGVCQKGGCRSEPIQMENsMGTLRTsIsVERQIHKLQDW |
| P30411 | S373 | SIGNOR | BDKRB2 BKR2 | KGGCRSEPIQMENsMGTLRTsIsVERQIHKLQDWAGSRQ__ |
| P30411 | S375 | SIGNOR | BDKRB2 BKR2 | GCRSEPIQMENsMGTLRTsIsVERQIHKLQDWAGSRQ____ |
| P31327 | S835 | Sugiyama | CPS1 | MCHPsIEGFTPRLPMNKEWPsNLDLRKELSEPSsTRIyAIA |
| P32245 | S329 | GPS6|SIGNOR|ELM|EPSD | MC4R | LRKtFKEIICCYPLGGLCDLssRY_________________ |
| P32245 | S330 | GPS6|SIGNOR|ELM|EPSD | MC4R | RKtFKEIICCYPLGGLCDLssRY__________________ |
| P32245 | T312 | SIGNOR|ELM | MC4R | MCNSIIDPLIYALRSQELRKtFKEIICCYPLGGLCDLssRY |
| P33993 | S314 | Sugiyama | MCM7 CDC47 MCM2 | SETyLEAHRIVKMNKSEDDEsGAGELtREELRQIAEEDFyE |
| P34932 | T364 | Sugiyama | HSPA4 APG2 HSPH2 | ATRIPAVKEKISKFFGKELsttLNADEAVTRGCALQCAILs |
| P35226 | S251 | Sugiyama | BMI1 PCGF4 RNF51 | CKRMKISHQRDGLTNAGELEsDsGsDKANSPAGGIPSTSSC |
| P35241 | T564 | EPSD|PSP | RDX | KTQNDVLHAENVKAGRDKYKtLRQIRQGNtKQRIDEFEAM_ |
| P35346 | T333 | PSP | SSTR5 | QSFQKVLCLRKGSGAKDADAtEPRPDRIRQQQEAtPPAHRA |
| P35367 | S398 | GPS6|ELM|EPSD|PSP | HRH1 | sGsNtGLDYIKFTWKRLRsHsRQYVSGLHMNRERKAAKQLG |
| P35372 | S357 | SIGNOR | OPRM1 MOR1 | LyAFLDENFKRCFREFCIPtssNIEQQNsTRIRQNtRDHPs |
| P35372 | S358 | SIGNOR | OPRM1 MOR1 | yAFLDENFKRCFREFCIPtssNIEQQNsTRIRQNtRDHPst |
| P35372 | S377 | EPSD|PSP | OPRM1 MOR1 | ssNIEQQNsTRIRQNtRDHPstANtVDRTNHQLENLEAEtA |
| P35372 | T356 | SIGNOR | OPRM1 MOR1 | VLyAFLDENFKRCFREFCIPtssNIEQQNsTRIRQNtRDHP |
| P35626 | S487 | Sugiyama | GRK3 ADRBK2 BARK2 | PPPLIPPRGEVNAADAFDIGsFDEEDtKGIKLLDCDQELYK |
| P35626 | T493 | Sugiyama | GRK3 ADRBK2 BARK2 | PRGEVNAADAFDIGsFDEEDtKGIKLLDCDQELYKNFPLVI |
| P35659 | S231 | Sugiyama | DEK | SGMARKAKRTKCPEILsDEsssDEDEKKNKEEssDDEDKEs |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37840 | S129 | GPS6|SIGNOR|ELM|EPSD|PSP | SNCA NACP PARK1 | QEGILEDMPVDPDNEAyEMPsEEGyQDyEPEA_________ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39687 | S104 | Sugiyama | ANP32A C15orf1 LANP MAPM PHAP1 | AEKCPNLTHLNLsGNKIKDLstIEPLKKLENLKsLDLFNCE |
| P41143 | S363 | GPS6|SIGNOR|ELM|EPSD|PSP | OPRD1 OPRD | SsFSRAREATARERVtACtPsDGPGGGAAA___________ |
| P41143 | T358 | GPS6|SIGNOR|ELM|EPSD | OPRD1 OPRD | GRPDPSsFSRAREATARERVtACtPsDGPGGGAAA______ |
| P41143 | T361 | GPS6|ELM|EPSD|PSP | OPRD1 OPRD | DPSsFSRAREATARERVtACtPsDGPGGGAAA_________ |
| P41146 | S346 | PSP | OPRL1 OOR ORL1 | FKACFRKFCCASALRRDVQVsDRVRsIAKDVALACKtsETV |
| P41146 | S351 | PSP | OPRL1 OOR ORL1 | RKFCCASALRRDVQVsDRVRsIAKDVALACKtsETVPRPA_ |
| P41146 | S363 | PSP | OPRL1 OOR ORL1 | VQVsDRVRsIAKDVALACKtsETVPRPA_____________ |
| P41146 | T362 | PSP | OPRL1 OOR ORL1 | DVQVsDRVRsIAKDVALACKtsETVPRPA____________ |
| P41227 | S213 | Sugiyama | NAA10 ARD1 ARD1A TE2 | ACREEKGLAAEDsGGDsKDLsEVsEtTEstDVKDssEAsDs |
| P41227 | S216 | Sugiyama | NAA10 ARD1 ARD1A TE2 | EEKGLAAEDsGGDsKDLsEVsEtTEstDVKDssEAsDsAs_ |
| P43121 | T298 | Sugiyama | MCAM MUC18 | PPPHFSISKQNPstREAEEEttNDNGVLVLEPARKEHSGRY |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P47756 | T202 | Sugiyama | CAPZB | SGsGtMNLGGsLtRQMEKDEtVsDCsPHIANIGRLVEDMEN |
| P49321 | S176 | Sugiyama | NASP | EAKKTEDKSLAKPEtDKEQDsEMEKGGREDMDIsKsAEEPQ |
| P49588 | Y192 | Sugiyama | AARS1 AARS | KDNFWEMGDtGPCGPCsEIHyDRIGGRDAAHLVNQDDPNVL |
| P50502 | S79 | Sugiyama | ST13 AAG2 FAM10A1 HIP SNC6 | KPDSKKVEEDLKADEPssEEsDLEIDKEGVIEPDTDAPQEM |
| P51681 | S336 | GPS6|ELM|EPSD | CCR5 CMKBR5 | IAKRFCKCCSIFQQEAPERAssVyTRsTGEQEIsVGL____ |
| P51681 | S337 | GPS6|ELM|EPSD | CCR5 CMKBR5 | AKRFCKCCSIFQQEAPERAssVyTRsTGEQEIsVGL_____ |
| P51681 | S342 | GPS6|ELM|EPSD | CCR5 CMKBR5 | KCCSIFQQEAPERAssVyTRsTGEQEIsVGL__________ |
| P51681 | S349 | GPS6|ELM|EPSD | CCR5 CMKBR5 | QEAPERAssVyTRsTGEQEIsVGL_________________ |
| P53985 | S467 | Sugiyama | SLC16A1 MCT1 | LLAKEQKANEQKKEsKEEEtsIDVAGKPNEVTKAAEsPDQK |
| P53985 | T466 | Sugiyama | SLC16A1 MCT1 | RLLAKEQKANEQKKEsKEEEtsIDVAGKPNEVTKAAEsPDQ |
| P53999 | S118 | Sugiyama | SUB1 PC4 RPO2TC1 | PGRKGIsLNPEQWsQLKEQIsDIDDAVRKL___________ |
| P53999 | S9 | Sugiyama | SUB1 PC4 RPO2TC1 | ____________MPKSKELVsssssGsDsDsEVDKKLKRKK |
| P54578 | S492 | Sugiyama | USP14 TGT | WHIAYVLLYGPRRVEIMEEEsEQ__________________ |
| P54652 | T229 | Sugiyama | HSPA2 | DVSILTIEDGIFEVKstAGDtHLGGEDFDNRMVSHLAEEFK |
| P55060 | S366 | Sugiyama | CSE1L CAS XPO2 | KVIVPNMEFRAADEEAFEDNsEEyIRRDLEGsDIDTRRRAA |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S368 | Sugiyama | ACTB | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | T318 | Sugiyama | ACTB | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62081 | S174 | Sugiyama | RPS7 | IKVHLDKAQQNNVEHKVEtFsGVyKKLTGKDVNFEFPEFQL |
| P62263 | S137 | Sugiyama | RPS14 PRO2640 | RALARSGMKIGRIEDVtPIPsDstRRKGGRRGRRL______ |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | T320 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P63104 | S28 | Sugiyama | YWHAZ | QKAKLAEQAERyDDMAACMKsVtEQGAELsNEERNLLsVAy |
| P63220 | S68 | Sugiyama | RPS21 | GQFKtyAICGAIRRMGEsDDsILRLAKADGIVSKNF_____ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S368 | Sugiyama | ACTG1 ACTG | sLstFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | T318 | Sugiyama | ACTG1 ACTG | VLsGGttMyPGIADRMQKEItALAPstMKIKIIAPPERKYs |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | T319 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | T320 | Sugiyama | ACTC1 ACTC | VLSGGtTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | T320 | Sugiyama | ACTA1 ACTA | VMSGGTTMYPGIADRMQKEItALAPstMKIKIIAPPERKYS |
| P68363 | T73 | Sugiyama | TUBA1B | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| P68363 | T80 | Sugiyama | TUBA1B | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| P98082 | S241 | Sugiyama | DAB2 DOC2 | tPPDLNsPtEsKDILLVDLNsEIDtNQNSLRENPFLTNGIT |
| Q01105 | T169 | Sugiyama | SET | NKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQTQNK |
| Q01130 | S212 | Sugiyama | SRSF2 SFRS2 | PPPVsKRESKSRSRsKsPPKsPEEEGAVss___________ |
| Q04637 | S1430 | Sugiyama | EIF4G1 EIF4F EIF4G EIF4GI | GQDIGAFVAEQKVEyTLGEEsEAPGQRALPsEELNRQLEKL |
| Q04726 | S197 | Sugiyama | TLE3 KIAA1547 | HLTVKDEKNHHELDHREREssANNsVsPsEsLRAsEKHRGs |
| Q04864 | S272 | Sugiyama | REL | AITEPVTVKMQLRRPSDQEVsEsMDFRYLPDEKDTYGNKAK |
| Q07021 | S201 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | ALVLDCHyPEDEVGQEDEAEsDIFsIREVsFQstGESEWKD |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q08211 | S125 | Sugiyama | DHX9 DDX9 LKP NDH2 | LPttMGGPLPPHLALKAENNsEVGAsGyGVPGPTWDRGANL |
| Q12904 | T280 | Sugiyama | AIMP1 EMAP2 SCYE1 | PDKELNPKKKIWEQIQPDLHtNDECVAtyKGVPFEVKGKGV |
| Q13011 | S43 | Sugiyama | ECH1 | NYPGLSISLRLtGssAQEEAsGVALGEAPDHSYESLRVTSA |
| Q13057 | S507 | Sugiyama | COASY PSEC0106 | WTAVIPETEAVRRIVERDGLsEAAAQSRLQSQMSGQQLVEQ |
| Q13263 | S479 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | ssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERLDLDLtA |
| Q13283 | S232 | Sugiyama | G3BP1 G3BP | EEKPEPVLEETAPEDAQKsssPAPADIAQtVQEDLRtFsWA |
| Q13509 | S115 | Sugiyama | TUBB3 TUBB4 | SGAGNNWAKGHytEGAELVDsVLDVVRKECENCDCLQGFQL |
| Q13509 | S420 | GPS6|ELM|EPSD | TUBB3 TUBB4 | GEGMDEMEFtEAESNMNDLVsEYQQYQDATAEEEGEMYEDD |
| Q13509 | S444 | GPS6|ELM|EPSD | TUBB3 TUBB4 | QYQDATAEEEGEMYEDDEEEsEAQGPK______________ |
| Q13509 | T409 | GPS6|ELM|EPSD | TUBB3 TUBB4 | FRRKAFLHWYTGEGMDEMEFtEAESNMNDLVsEYQQYQDAT |
| Q13541 | S112 | Sugiyama | EIF4EBP1 | EAsQsHLRNsPEDKRAGGEEsQFEMDI______________ |
| Q13547 | S421 | Sugiyama | HDAC1 RPD3L1 | PDKRIsICssDKRIACEEEFsDsEEEGEGGRKNsSNFKKAK |
| Q13885 | S115 | Sugiyama | TUBB2A TUBB2 | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q14152 | S1308 | Sugiyama | EIF3A EIF3S10 KIAA0139 | DLRDDRDRRGPPLRSEREEVsSWRRADDRKDDRVEERDPPR |
| Q14152 | S907 | Sugiyama | EIF3A EIF3S10 KIAA0139 | DSRWGDRDsEGtWRKGPEADsEWRRGPPEKEWRRGEGRDED |
| Q14152 | T1378 | Sugiyama | EIF3A EIF3S10 KIAA0139 | AEKDREsLRRTKNEtDEDGWttVRR________________ |
| Q14155 | S518 | Sugiyama | ARHGEF7 COOL1 KIAA0142 P85SPR PAK3BP PIXB Nbla10314 | ERYLLLFPNVLLMLSASPRMsGFIyQGKLPtTGMTITKLED |
| Q14203 | S417 | Sugiyama | DCTN1 | KKNQELEVVRQQRERLQEELsQAEstIDELKEQVDAALGAE |
| Q14204 | T1307 | Sugiyama | DYNC1H1 DHC1 DNCH1 DNCL DNECL DYHC KIAA0325 | FGRLKDDREKCAKAKEALELtDtGLLsGSEERVQVALEELQ |
| Q14257 | T301 | Sugiyama | RCN2 ERC55 | KKLsEEEILENPDLFLtsEAtDyGRQLHDDyFyHDEL____ |
| Q14568 | S50 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | MSLIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKL |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14940 | S702 | SIGNOR|EPSD|PSP | SLC9A5 NHE5 | NGKHRGLGFQDTAAVILTVEsEEEEEEsDssEtEKEDDEGI |
| Q14940 | S709 | SIGNOR|EPSD|PSP | SLC9A5 NHE5 | GFQDTAAVILTVEsEEEEEEsDssEtEKEDDEGIIFVARAT |
| Q14940 | S711 | SIGNOR|EPSD|PSP | SLC9A5 NHE5 | QDTAAVILTVEsEEEEEEsDssEtEKEDDEGIIFVARATSE |
| Q14940 | S712 | SIGNOR|EPSD|PSP | SLC9A5 NHE5 | DTAAVILTVEsEEEEEEsDssEtEKEDDEGIIFVARATSEV |
| Q14940 | T714 | SIGNOR|EPSD|PSP | SLC9A5 NHE5 | AAVILTVEsEEEEEEsDssEtEKEDDEGIIFVARATSEVLQ |
| Q15021 | S1330 | Sugiyama | NCAPD2 CAPD2 CNAP1 KIAA0159 | sQRAPsAKKPSTGSRyQPLAstAsDNDFVtPEPRRTTRRHP |
| Q15052 | S488 | Sugiyama | ARHGEF6 COOL2 KIAA0006 PIXA | ERYLMLFSNVLIMLSASPRMsGFIYQGKIPIAGTVVTRLDE |
| Q15084 | S428 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | EREPWDGRDGELPVEDDIDLsDVELDDLGKDEL________ |
| Q15084 | T166 | Sugiyama | PDIA6 ERP5 P5 TXNDC7 | YSSGKQGRSDsSSKKDVIELtDDsFDKNVLDSEDVWMVEFY |
| Q15758 | S539 | Sugiyama | SLC1A5 ASCT2 M7V1 RDR RDRC | PLLKHyRGPAGDAtVAsEKEsVM__________________ |
| Q15796 | T197 | EPSD|PSP | SMAD2 MADH2 MADR2 | PVLVPRHTEILTELPPLDDYtHSIPENTNFPAGIEPQSNYI |
| Q16143 | S118 | GPS6|EPSD | SNCB | VAQEAAEEPLIEPLMEPEGEsYEDPPQEEyQEYEPEA____ |
| Q16539 | T123 | SIGNOR|EPSD|PSP | MAPK14 CSBP CSBP1 CSBP2 CSPB1 MXI2 SAPK2A | YLVTHLMGADLNNIVKCQKLtDDHVQFLIYQILRGLKYIHs |
| Q562R1 | T107 | Sugiyama | ACTBL2 | WYHTFYNELRVAPDEHPILLtEAPLNPKINREKMTQIMFEA |
| Q56P03 | S111 | Sugiyama | EAPP C14orf11 BM-036 | NGKVATAPTRyYDDIyFDsDsEDEDRAVQVtKKKKKKQHKI |
| Q58FF6 | T165 | Sugiyama | HSP90AB4P | DHGEPIDRDTKVILHLKEDQtEyLEERWVKEVVKKHPQFIG |
| Q58FF7 | T169 | Sugiyama | HSP90AB3P HSP90BC | DHGEPIGRGTKVILHLKEDQtEyLEERRVKEVVKKHsQFIG |
| Q5T4S7 | S2910 | Sugiyama | UBR4 KIAA0462 KIAA1307 RBAF600 | GGsVGsEsGGsAVDsVAGEHsVsGRSSAYGDATAEGHPAGP |
| Q6P996 | S779 | Sugiyama | PDXDC1 KIAA0251 | QHtDQtEAFQKGVPHPEDDHsQVEGPEsLR___________ |
| Q6PKG0 | S631 | Sugiyama | LARP1 KIAA0731 LARP | EEMEQMDGRKNtFtAWsDEEsDyEIDDRDVNKILIVtQtPH |
| Q6PKG0 | T769 | Sugiyama | LARP1 KIAA0731 LARP | ALANKLFGAPEPstIARsLPttVPEsPNyRNtRtPRtPRtP |
| Q6S8J3 | S1068 | Sugiyama | POTEE A26C1A POTE2 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q6UXH1 | S295 | Sugiyama | CRELD2 UNQ185/PRO211 | KECISGYAREHGQCADVDECsLAEKtCVRKNENCYNTPGSY |
| Q71U36 | T73 | Sugiyama | TUBA1A TUBA3 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q71U36 | T80 | Sugiyama | TUBA1A TUBA3 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q7Z460 | S246 | Sugiyama | CLASP1 KIAA0622 MAST1 | VQKSGNMIQSANDKNFDDEDsVDGNRPssAsStSSKAPPSS |
| Q86XZ4 | S166 | Sugiyama | SPATS2 SCR59 SPATA10 Nbla00526 | sLSEGLETLSIDARELEDPEsAMLDTLDRTGSMLQNGVSDF |
| Q8IWE2 | T401 | Sugiyama | FAM114A1 NOXP20 | TPDKLNKAMKRAHDWVEEDQtVVSVDVAKVSEEETKKEEKE |
| Q8IWX8 | S822 | Sugiyama | CHERP DAN26 SCAF6 | SKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRLGEE |
| Q8IWX8 | T819 | Sugiyama | CHERP DAN26 SCAF6 | RSRSKSYSPGRRRRsRsRsPtPPssAGLGsNsAPPIPDSRL |
| Q8N4Q1 | T127 | Sugiyama | CHCHD4 MIA40 | QEDEDEEEEREKKPAEQAEEtAPIEATAtKEEEGss_____ |
| Q8N4Q1 | T135 | Sugiyama | CHCHD4 MIA40 | EREKKPAEQAEEtAPIEATAtKEEEGss_____________ |
| Q8NBS9 | S292 | Sugiyama | TXNDC5 TLP46 UNQ364/PRO700 | KKVDQYKGKRDLEsLREyVEsQLQRTETGATETVTPSEAPV |
| Q8NEM2 | S42 | Sugiyama | SHCBP1 | GWAVEQELASLEKGLFQDEDsCsDCsYRDKPGssLQSFMPE |
| Q8NEN9 | S496 | Sugiyama | PDZD8 PDZK8 | SGYEEEAAGLTVDTESRELDsEFEDLAsDVRAQNEFKDEAQ |
| Q8TAM6 | S280 | Sugiyama | ERMN KIAA1189 | TISYRKIRKGNTKQRIDEFEsMMHL________________ |
| Q8TDU6 | S310 | PSP | GPBAR1 TGR5 | PWRAAAQRCLQGLWGRASRDsPGPSIAYHPSsQssVDLDLN |
| Q8TDU6 | S321 | PSP | GPBAR1 TGR5 | GLWGRASRDsPGPSIAYHPSsQssVDLDLN___________ |
| Q8TDU6 | S323 | PSP | GPBAR1 TGR5 | WGRASRDsPGPSIAYHPSsQssVDLDLN_____________ |
| Q8TDU6 | S324 | PSP | GPBAR1 TGR5 | GRASRDsPGPSIAYHPSsQssVDLDLN______________ |
| Q8WVJ2 | S142 | Sugiyama | NUDCD2 | LTLERFQKENPGFDFsGAEIsGNytKGGPDFsNLEK_____ |
| Q92769 | S422 | Sugiyama | HDAC2 | PDKRIsIRAsDKRIACDEEFsDsEDEGEGGRRNVADHKKGA |
| Q92847 | S252 | PSP | GHSR | YSLIGRKLWRRRRGDAVVGAsLRDQNHKQtVKMLAVVVFAF |
| Q92890 | T210 | Sugiyama | UFD1 UFD1L | DFDAPLGYKEPERQVQHEEstEGEADHsGyAGELGFRAFsG |
| Q92973 | S339 | Sugiyama | TNPO1 KPNB2 MIP1 TRN | SDIDIILLKGDVEEDEtIPDsEQDIRPRFHRSRTVAQQHDE |
| Q96A54 | S205 | SIGNOR|PSP | ADIPOR1 PAQR1 TESBP1A CGI-45 | SFSWLFHTVYCHSEKVSRTFsKLDYSGIALLIMGSFVPWLY |
| Q96A54 | S7 | EPSD|PSP | ADIPOR1 PAQR1 TESBP1A CGI-45 | ______________MSSHKGsVVAQGNGAPASNREADtVEL |
| Q96A54 | T24 | EPSD|PSP | ADIPOR1 PAQR1 TESBP1A CGI-45 | HKGsVVAQGNGAPASNREADtVELAELGPLLEEKGKRVIAN |
| Q96A54 | T53 | EPSD|PSP | ADIPOR1 PAQR1 TESBP1A CGI-45 | LLEEKGKRVIANPPKAEEEQtCPVPQEEEEEVRVLtLPLQA |
| Q96C19 | S237 | Sugiyama | EFHD2 SWS1 | ERKKQAEEMKQRKAAFKELQsTFK_________________ |
| Q96HE7 | S143 | Sugiyama | ERO1A ERO1L UNQ434/PRO865 | EANNLIEECEQAERLGAVDEsLsEEtQKAVLQWTKHDDSSD |
| Q96K76 | S903 | Sugiyama | USP47 | LSLQQQQDGDNGDssKstEtsDFENIEsPLNERDsSAsVDN |
| Q96PZ0 | S23 | Sugiyama | PUS7 KIAA1897 | MTEMTGVSLKRGALVVEDNDsGVPVEETKKQKLsECsLTKG |
| Q96QK1 | S760 | Sugiyama | VPS35 MEM3 TCCCTA00141 | IQVLNQLIQKIREDLPNLEssEEtEQINKHFHNtLEHLRLR |
| Q96QK1 | T763 | Sugiyama | VPS35 MEM3 TCCCTA00141 | LNQLIQKIREDLPNLEssEEtEQINKHFHNtLEHLRLRREs |
| Q96S66 | S59 | Sugiyama | CLCC1 KIAA0761 MCLC | MRKSQAKYGISGEKDVSPDLsCADEIsECyHKLDSLTYKID |
| Q96S66 | S65 | Sugiyama | CLCC1 KIAA0761 MCLC | KYGISGEKDVSPDLsCADEIsECyHKLDSLTYKIDECEKKK |
| Q96S66 | Y68 | Sugiyama | CLCC1 KIAA0761 MCLC | ISGEKDVSPDLsCADEIsECyHKLDSLTYKIDECEKKKRED |
| Q99613 | S154 | Sugiyama | EIF3C EIF3S8 | NAKALSTLRQKIRKyNRDFEsHItSyKQNPEQsADEDAEKN |
| Q99733 | S125 | Sugiyama | NAP1L4 NAP2 | KRREFItGDVEPtDAEsEWHsENEEEEKLAGDMKSKVVVTE |
| Q99733 | T117 | Sugiyama | NAP1L4 NAP2 | ALyQPLFDKRREFItGDVEPtDAEsEWHsENEEEEKLAGDM |
| Q99816 | S299 | Sugiyama | TSG101 | QEVAEVDKNIELLKKKDEELssALEKMENQsENNDIDEVII |
| Q9BQE3 | T73 | Sugiyama | TUBA1C TUBA6 | FsEtGAGKHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLI |
| Q9BQE3 | T80 | Sugiyama | TUBA1C TUBA6 | KHVPRAVFVDLEPtVIDEVRtGtyRQLFHPEQLItGKEDAA |
| Q9BVA1 | S115 | Sugiyama | TUBB2B | sGAGNNWAKGHytEGAELVDsVLDVVRKESESCDCLQGFQL |
| Q9BVS4 | S380 | Sugiyama | RIOK2 RIO2 | EEsEGCYCRssGDPEQIKEDsLsEEsADARsFEMTEFNQAL |
| Q9BW91 | S343 | Sugiyama | NUDT9 NUDT10 PSEC0099 UNQ3012/PRO9771 | SHSQFIKLVAEKRDAHWSEDsEADCHAL_____________ |
| Q9BX95 | T114 | Sugiyama | SGPP1 SPP1 | AAELGPAsPRRAGALRRNsLtGEEGQLARVSNWPLYCLFCF |
| Q9BYW2 | S1415 | Sugiyama | SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069 | KNDIKDRGPLKKRRQEIEsDsEsDGELQDRKKVRVEVEQGE |
| Q9BYW2 | S1417 | Sugiyama | SETD2 HIF1 HYPB KIAA1732 KMT3A SET2 HSPC069 | DIKDRGPLKKRRQEIEsDsEsDGELQDRKKVRVEVEQGETS |
| Q9BYX7 | S368 | Sugiyama | POTEKP ACTBL3 FKSG30 | SLSTFQQMWISKQEyDEsGPsIVHRKCF_____________ |
| Q9H2K8 | S331 | Sugiyama | TAOK3 DPK JIK KDS MAP3K18 | ILFQETRNGPLNEsQEDEEDsEHGTsLNREMDSLGSNHSIP |
| Q9H3P7 | S393 | Sugiyama | ACBD3 GCP60 GOCAP1 GOLPH1 | SMWTRPQIKDFKEKIQQDADsVItVGRGEVVTVRVPTHEEG |
| Q9H4A5 | S27 | Sugiyama | GOLPH3L GPP34R | RARRTEISKNSEKKMEsEEDsNWEKSPDNEDSGDSKDIRLT |
| Q9NPQ8 | T441 | Sugiyama | RIC8A | AARGLMAGGRPEGQysEDEDtDtDEyKEAKAsINPVTGRVE |
| Q9NR28 | S230 | Sugiyama | DIABLO SMAC | EAQIEELRQKTQEEGEERAEsEQEAyLRED___________ |
| Q9NR30 | S121 | Sugiyama | DDX21 | PIEKKVVSSKTKKVTKNEEPsEEEIDAPKPKKMKKEKEMNG |
| Q9NRX4 | T119 | Sugiyama | PHPT1 PHP14 CGI-202 HSPC141 | PAQHAISTEKIKAKyPDyEVtWANDGy______________ |
| Q9NWB6 | S77 | Sugiyama | ARGLU1 | RsRstNTAVSRRERDRERAssPPDRIDIFGRTVSKRSSLDE |
| Q9NYU2 | T371 | Sugiyama | UGGT1 GT UGCGL1 UGGT UGT1 UGTR | QNFPTKARAITKTAVsSELRtEVEENQKYFKGTLGLQPGDS |
| Q9P258 | S15 | Sugiyama | RCC2 KIAA1470 TD60 | ______MPRKKAAAAAWEEPssGNGtARAGPRKRGGPAGRK |
| Q9P2I0 | S419 | Sugiyama | CPSF2 CPSF100 KIAA1367 | EKLKKEAAKKLEQSKEADIDssDEsDIEEDIDQPSAHKTKH |
| Q9UBV2 | S66 | Sugiyama | SEL1L TSA305 UNQ128/PRO1063 | KDHTTAGRVVAGQIFLDsEEsELEssIQEEEDSLKSQEGES |
| Q9UBV2 | S71 | Sugiyama | SEL1L TSA305 UNQ128/PRO1063 | AGRVVAGQIFLDsEEsELEssIQEEEDSLKSQEGESVTEDI |
| Q9UI30 | T123 | Sugiyama | TRMT112 AD-001 HSPC152 HSPC170 | SGRMFPISRGIPNMLLsEEEtEs__________________ |
| Q9UQ80 | T386 | Sugiyama | PA2G4 EBP1 | tQKKKKKKAsKtAENAtsGEtLEENEAGD____________ |
| Q9Y2W7 | S95 | EPSD|PSP | KCNIP3 CSEN DREAM KCHIP3 | QPEGLDQLQAQTKFTKKELQsLYRGFKNECPTGLVDEDTFK |
| Q9Y2X7 | S385 | Sugiyama | GIT1 | DNLELsLRSQSDLDDQHDyDsVAsDEDtDQEPLRSTGATRS |
| Q9Y3F4 | S312 | Sugiyama | STRAP MAWD UNRIP | WQTVVGKtyGLWKCVLPEEDsGELAKPKIGFPETTEEELEE |
| Q9Y3U8 | S91 | Sugiyama | RPL36 | KFIKKRVGTHIRAKRKREELsNVLAAMRKAAAKKD______ |
| Q9Y5S9 | S56 | Sugiyama | RBM8A RBM8 HSPC114 MDS014 | KGRGFGsEEGsRARMREDyDsVEQDGDEPGPQRSVEGWILF |
| Q9Y5X5 | S519 | PSP | NPFFR2 GPR74 NPFF2 NPGPR | KsAEKPQQELVMEELKEttNssEI_________________ |
| Q9Y5X5 | S520 | PSP | NPFFR2 GPR74 NPFF2 NPGPR | sAEKPQQELVMEELKEttNssEI__________________ |
| Q9Y5X5 | T516 | PSP | NPFFR2 GPR74 NPFF2 NPGPR | LYRKsAEKPQQELVMEELKEttNssEI______________ |
| Q9Y5X5 | T517 | PSP | NPFFR2 GPR74 NPFF2 NPGPR | YRKsAEKPQQELVMEELKEttNssEI_______________ |
| Q9Y696 | T231 | Sugiyama | CLIC4 | PKEMTGIWRYLtNAysRDEFtNtCPsDKEVEIAysDVAKRL |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 1.480768e-08 | 7.830 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.343917e-07 | 6.630 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 3.148983e-07 | 6.502 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.833186e-06 | 5.316 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 9.405747e-06 | 5.027 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 9.709356e-06 | 5.013 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 9.424797e-06 | 5.026 | 1 | 0 |
| Membrane Trafficking | R-HSA-199991 | 1.508959e-05 | 4.821 | 1 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 2.593309e-05 | 4.586 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.650755e-05 | 4.438 | 0 | 0 |
| M Phase | R-HSA-68886 | 3.966827e-05 | 4.402 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.154800e-04 | 3.937 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.195617e-04 | 3.922 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.320453e-04 | 3.879 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.362031e-04 | 3.866 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.291659e-04 | 3.889 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.858345e-04 | 3.731 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.062529e-04 | 3.686 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.136941e-04 | 3.670 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.157152e-04 | 3.666 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 2.368601e-04 | 3.626 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 2.444963e-04 | 3.612 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.546713e-04 | 3.594 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.546713e-04 | 3.594 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.701072e-04 | 3.568 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 3.063858e-04 | 3.514 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 3.546843e-04 | 3.450 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.695370e-04 | 3.432 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.019601e-04 | 3.396 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 3.919468e-04 | 3.407 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.259403e-04 | 3.371 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.396895e-04 | 3.357 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.662058e-04 | 3.331 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 4.760718e-04 | 3.322 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.898861e-04 | 3.310 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 5.007573e-04 | 3.300 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 5.290716e-04 | 3.276 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 5.543865e-04 | 3.256 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 5.635507e-04 | 3.249 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 5.679088e-04 | 3.246 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 6.339162e-04 | 3.198 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 6.408605e-04 | 3.193 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.173539e-04 | 3.144 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.324862e-04 | 3.135 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.438040e-04 | 3.129 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.839936e-04 | 3.054 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 8.839936e-04 | 3.054 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.932719e-04 | 3.049 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 9.047930e-04 | 3.043 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 9.047930e-04 | 3.043 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 7.999413e-04 | 3.097 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 8.606548e-04 | 3.065 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 7.999413e-04 | 3.097 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 7.999413e-04 | 3.097 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 9.058685e-04 | 3.043 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 9.812413e-04 | 3.008 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 9.930450e-04 | 3.003 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.049655e-03 | 2.979 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.069816e-03 | 2.971 | 1 | 1 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.179530e-03 | 2.928 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 1.206451e-03 | 2.918 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.289279e-03 | 2.890 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.403042e-03 | 2.853 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.403042e-03 | 2.853 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.419810e-03 | 2.848 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 1.425852e-03 | 2.846 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.430675e-03 | 2.844 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.905347e-03 | 2.720 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.900554e-03 | 2.721 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 1.878851e-03 | 2.726 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.726467e-03 | 2.763 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.905347e-03 | 2.720 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.915266e-03 | 2.718 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.965926e-03 | 2.706 | 1 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.974572e-03 | 2.705 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 1.974572e-03 | 2.705 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 2.023808e-03 | 2.694 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.203432e-03 | 2.657 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.108764e-03 | 2.676 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 2.317176e-03 | 2.635 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.352932e-03 | 2.628 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 2.575296e-03 | 2.589 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.826462e-03 | 2.549 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.826462e-03 | 2.549 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.826462e-03 | 2.549 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.826462e-03 | 2.549 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.043143e-03 | 2.517 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.282626e-03 | 2.484 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.282626e-03 | 2.484 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.316380e-03 | 2.479 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.658719e-03 | 2.437 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.023033e-03 | 2.395 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.023033e-03 | 2.395 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.937007e-03 | 2.405 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 3.910335e-03 | 2.408 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.098436e-03 | 2.387 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 4.153840e-03 | 2.382 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 4.153840e-03 | 2.382 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.609105e-03 | 2.336 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.642105e-03 | 2.333 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 4.642105e-03 | 2.333 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 4.989402e-03 | 2.302 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 4.989402e-03 | 2.302 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 5.041112e-03 | 2.297 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.056717e-03 | 2.296 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.079458e-03 | 2.294 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.203653e-03 | 2.284 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 5.206772e-03 | 2.283 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 5.206772e-03 | 2.283 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.114160e-03 | 2.214 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 5.900989e-03 | 2.229 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 5.842404e-03 | 2.233 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 6.198046e-03 | 2.208 | 1 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.421035e-03 | 2.192 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.699348e-03 | 2.174 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 7.081377e-03 | 2.150 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.144676e-03 | 2.146 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 7.214339e-03 | 2.142 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.056381e-03 | 2.094 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 8.090708e-03 | 2.092 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.649399e-03 | 2.063 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 9.364034e-03 | 2.029 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.593575e-03 | 2.066 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 9.710251e-03 | 2.013 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 9.737762e-03 | 2.012 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 9.784658e-03 | 2.009 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.015464e-02 | 1.993 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.106031e-02 | 1.956 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.120997e-02 | 1.950 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 1.134986e-02 | 1.945 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 1.044324e-02 | 1.981 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.092776e-02 | 1.961 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 1.064862e-02 | 1.973 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 1.093843e-02 | 1.961 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.093843e-02 | 1.961 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.179513e-02 | 1.928 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.179513e-02 | 1.928 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.228532e-02 | 1.911 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.228532e-02 | 1.911 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.244677e-02 | 1.905 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.244677e-02 | 1.905 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.246578e-02 | 1.904 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.343255e-02 | 1.872 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.379043e-02 | 1.860 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.446249e-02 | 1.840 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.467637e-02 | 1.833 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.505883e-02 | 1.822 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.526273e-02 | 1.816 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.446249e-02 | 1.840 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.566537e-02 | 1.805 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.581723e-02 | 1.801 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.642934e-02 | 1.784 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.737999e-02 | 1.760 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.765967e-02 | 1.753 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.765967e-02 | 1.753 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.846050e-02 | 1.734 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.846050e-02 | 1.734 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 1.847139e-02 | 1.734 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 1.853738e-02 | 1.732 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 1.879883e-02 | 1.726 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.984571e-02 | 1.702 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.984571e-02 | 1.702 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.027960e-02 | 1.693 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.313625e-02 | 1.636 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.256051e-02 | 1.647 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.122756e-02 | 1.673 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 2.239643e-02 | 1.650 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.138130e-02 | 1.670 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.063835e-02 | 1.685 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.138130e-02 | 1.670 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.132042e-02 | 1.671 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.368085e-02 | 1.626 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.437537e-02 | 1.613 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 2.553368e-02 | 1.593 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.766717e-02 | 1.558 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.821230e-02 | 1.550 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 2.821230e-02 | 1.550 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 3.154296e-02 | 1.501 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 3.154296e-02 | 1.501 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 3.154296e-02 | 1.501 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 3.154296e-02 | 1.501 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.955381e-02 | 1.529 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 2.955381e-02 | 1.529 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.232678e-02 | 1.490 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.845328e-02 | 1.546 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.967489e-02 | 1.528 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 3.154296e-02 | 1.501 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.087424e-02 | 1.510 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.955381e-02 | 1.529 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.052628e-02 | 1.515 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 3.076916e-02 | 1.512 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 3.167789e-02 | 1.499 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 2.845328e-02 | 1.546 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.240263e-02 | 1.489 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.240263e-02 | 1.489 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 2.938323e-02 | 1.532 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 3.076916e-02 | 1.512 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.262101e-02 | 1.487 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 3.285217e-02 | 1.483 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.313591e-02 | 1.480 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 3.389922e-02 | 1.470 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.437200e-02 | 1.464 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.437200e-02 | 1.464 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 3.621518e-02 | 1.441 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 3.625582e-02 | 1.441 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 4.143813e-02 | 1.383 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.143813e-02 | 1.383 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.143813e-02 | 1.383 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.284723e-02 | 1.368 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 4.284723e-02 | 1.368 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 4.284723e-02 | 1.368 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.284723e-02 | 1.368 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 4.284723e-02 | 1.368 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.111288e-02 | 1.386 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 4.037011e-02 | 1.394 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 3.716323e-02 | 1.430 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.209084e-02 | 1.376 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.284723e-02 | 1.368 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 4.284723e-02 | 1.368 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 3.893957e-02 | 1.410 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.252754e-02 | 1.371 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 4.181078e-02 | 1.379 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.075656e-02 | 1.390 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.923776e-02 | 1.406 | 0 | 0 |
| S Phase | R-HSA-69242 | 4.276930e-02 | 1.369 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.143813e-02 | 1.383 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 3.912277e-02 | 1.408 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 3.874310e-02 | 1.412 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 3.923776e-02 | 1.406 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.075656e-02 | 1.390 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 4.289319e-02 | 1.368 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.289319e-02 | 1.368 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.490459e-02 | 1.348 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 4.726894e-02 | 1.325 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.726894e-02 | 1.325 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.747219e-02 | 1.324 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 4.771538e-02 | 1.321 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.791811e-02 | 1.320 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 4.797011e-02 | 1.319 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 4.925038e-02 | 1.308 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.955771e-02 | 1.305 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 5.108346e-02 | 1.292 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 5.108346e-02 | 1.292 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 5.329084e-02 | 1.273 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.436767e-02 | 1.265 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.436767e-02 | 1.265 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 5.436767e-02 | 1.265 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 5.438018e-02 | 1.265 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 5.440918e-02 | 1.264 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 5.440918e-02 | 1.264 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.440918e-02 | 1.264 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 5.443710e-02 | 1.264 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 5.767989e-02 | 1.239 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.218744e-02 | 1.206 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.955573e-02 | 1.225 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 6.627386e-02 | 1.179 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.626543e-02 | 1.179 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 6.606282e-02 | 1.180 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 6.606282e-02 | 1.180 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 5.778532e-02 | 1.238 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 5.778532e-02 | 1.238 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 6.349039e-02 | 1.197 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 5.767989e-02 | 1.239 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.203001e-02 | 1.207 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 6.702070e-02 | 1.174 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 6.650391e-02 | 1.177 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.759936e-02 | 1.170 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 6.586689e-02 | 1.181 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 5.855915e-02 | 1.232 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 6.647502e-02 | 1.177 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 6.739331e-02 | 1.171 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 6.627386e-02 | 1.179 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 5.767989e-02 | 1.239 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.767989e-02 | 1.239 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 6.804983e-02 | 1.167 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 6.849568e-02 | 1.164 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.932164e-02 | 1.159 | 1 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.017669e-02 | 1.154 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 7.051284e-02 | 1.152 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 7.051284e-02 | 1.152 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.060959e-02 | 1.151 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.060959e-02 | 1.151 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 7.212302e-02 | 1.142 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 7.278762e-02 | 1.138 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.311809e-02 | 1.136 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.345018e-02 | 1.134 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 7.345018e-02 | 1.134 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 7.357008e-02 | 1.133 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 7.546000e-02 | 1.122 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.598030e-02 | 1.119 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 7.598030e-02 | 1.119 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.598030e-02 | 1.119 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 7.598030e-02 | 1.119 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.720641e-02 | 1.112 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 7.729824e-02 | 1.112 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.909456e-02 | 1.102 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 7.967723e-02 | 1.099 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 7.967723e-02 | 1.099 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 9.588660e-02 | 1.018 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 9.588660e-02 | 1.018 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 9.588660e-02 | 1.018 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 9.588660e-02 | 1.018 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 9.776287e-02 | 1.010 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 9.776287e-02 | 1.010 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.035378e-02 | 1.095 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 8.109570e-02 | 1.091 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 8.109570e-02 | 1.091 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 9.973428e-02 | 1.001 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 9.932310e-02 | 1.003 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 8.049658e-02 | 1.094 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 8.429685e-02 | 1.074 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 9.776287e-02 | 1.010 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 9.973428e-02 | 1.001 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 8.035378e-02 | 1.095 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 8.489290e-02 | 1.071 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 8.310437e-02 | 1.080 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.035378e-02 | 1.095 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 9.973428e-02 | 1.001 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 9.973428e-02 | 1.001 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 8.362949e-02 | 1.078 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.803249e-02 | 1.009 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 9.641625e-02 | 1.016 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 8.108760e-02 | 1.091 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.192239e-02 | 1.037 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 9.323137e-02 | 1.030 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 9.210814e-02 | 1.036 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 9.973428e-02 | 1.001 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 8.761164e-02 | 1.057 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 9.320659e-02 | 1.031 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 9.588660e-02 | 1.018 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 8.108760e-02 | 1.091 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 9.804635e-02 | 1.009 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.018950e-01 | 0.992 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 1.021841e-01 | 0.991 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.024924e-01 | 0.989 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 1.025357e-01 | 0.989 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 1.025357e-01 | 0.989 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 1.025357e-01 | 0.989 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.025357e-01 | 0.989 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 1.025357e-01 | 0.989 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 1.025357e-01 | 0.989 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.025357e-01 | 0.989 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 1.025357e-01 | 0.989 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 1.028264e-01 | 0.988 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.067641e-01 | 0.972 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.070955e-01 | 0.970 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.070955e-01 | 0.970 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.070955e-01 | 0.970 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.070955e-01 | 0.970 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.140653e-01 | 0.943 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 1.149601e-01 | 0.939 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.149601e-01 | 0.939 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 1.149601e-01 | 0.939 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.149601e-01 | 0.939 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 1.162332e-01 | 0.935 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 1.162332e-01 | 0.935 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.162332e-01 | 0.935 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.182843e-01 | 0.927 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.182843e-01 | 0.927 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 1.198829e-01 | 0.921 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 1.214200e-01 | 0.916 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 1.219040e-01 | 0.914 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.219040e-01 | 0.914 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 1.219040e-01 | 0.914 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.221268e-01 | 0.913 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.221268e-01 | 0.913 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 1.222887e-01 | 0.913 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.945633e-01 | 0.711 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.945633e-01 | 0.711 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.945633e-01 | 0.711 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.945633e-01 | 0.711 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.945633e-01 | 0.711 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.945633e-01 | 0.711 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.945633e-01 | 0.711 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.945633e-01 | 0.711 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.945633e-01 | 0.711 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.382873e-01 | 0.859 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.382873e-01 | 0.859 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 1.382873e-01 | 0.859 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.382873e-01 | 0.859 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.382873e-01 | 0.859 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.771590e-01 | 0.557 | 0 | 0 |
| Defective TPMT causes TPMT deficiency | R-HSA-5578995 | 2.771590e-01 | 0.557 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.771590e-01 | 0.557 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.771590e-01 | 0.557 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 2.771590e-01 | 0.557 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.771590e-01 | 0.557 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.771590e-01 | 0.557 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 1.759114e-01 | 0.755 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.759114e-01 | 0.755 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 1.759114e-01 | 0.755 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 1.759114e-01 | 0.755 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 1.759114e-01 | 0.755 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.759114e-01 | 0.755 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 1.423999e-01 | 0.846 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 2.148828e-01 | 0.668 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.148828e-01 | 0.668 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 2.148828e-01 | 0.668 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.512891e-01 | 0.454 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.512891e-01 | 0.454 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 3.512891e-01 | 0.454 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 3.512891e-01 | 0.454 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.512891e-01 | 0.454 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.512891e-01 | 0.454 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.512891e-01 | 0.454 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.512891e-01 | 0.454 | 0 | 0 |
| Defective ABCB6 causes MCOPCB7 | R-HSA-5683371 | 3.512891e-01 | 0.454 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.512891e-01 | 0.454 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.512891e-01 | 0.454 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.512891e-01 | 0.454 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.512891e-01 | 0.454 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.512891e-01 | 0.454 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.512891e-01 | 0.454 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.512891e-01 | 0.454 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.512891e-01 | 0.454 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.512891e-01 | 0.454 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.512891e-01 | 0.454 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.679740e-01 | 0.775 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 1.679740e-01 | 0.775 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 2.545302e-01 | 0.594 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.545302e-01 | 0.594 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.545302e-01 | 0.594 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 2.545302e-01 | 0.594 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 1.947485e-01 | 0.711 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 1.947485e-01 | 0.711 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.529046e-01 | 0.816 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.529046e-01 | 0.816 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.376071e-01 | 0.861 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 1.376071e-01 | 0.861 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.376071e-01 | 0.861 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.376071e-01 | 0.861 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.376071e-01 | 0.861 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 1.734318e-01 | 0.761 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 1.734318e-01 | 0.761 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 2.224729e-01 | 0.653 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 2.224729e-01 | 0.653 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.224729e-01 | 0.653 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.224729e-01 | 0.653 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.943056e-01 | 0.531 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.943056e-01 | 0.531 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.943056e-01 | 0.531 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.178208e-01 | 0.379 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.178208e-01 | 0.379 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 4.178208e-01 | 0.379 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.178208e-01 | 0.379 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.178208e-01 | 0.379 | 0 | 0 |
| Defective SLC7A7 causes lysinuric protein intolerance (LPI) | R-HSA-5660862 | 4.178208e-01 | 0.379 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 1.541481e-01 | 0.812 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.509083e-01 | 0.600 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 2.509083e-01 | 0.600 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 2.509083e-01 | 0.600 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.509083e-01 | 0.600 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.509083e-01 | 0.600 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.509083e-01 | 0.600 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.509083e-01 | 0.600 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.509083e-01 | 0.600 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.509083e-01 | 0.600 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.515612e-01 | 0.819 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.337661e-01 | 0.477 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 3.337661e-01 | 0.477 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 3.337661e-01 | 0.477 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.337661e-01 | 0.477 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 3.337661e-01 | 0.477 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.337661e-01 | 0.477 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.337661e-01 | 0.477 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.894897e-01 | 0.722 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.798304e-01 | 0.553 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.798304e-01 | 0.553 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 2.398067e-01 | 0.620 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 2.398067e-01 | 0.620 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.822229e-01 | 0.739 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.984068e-01 | 0.702 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 1.984068e-01 | 0.702 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 1.984068e-01 | 0.702 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.273835e-01 | 0.643 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.631251e-01 | 0.580 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 2.631251e-01 | 0.580 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 3.090315e-01 | 0.510 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 3.090315e-01 | 0.510 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.725583e-01 | 0.429 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 3.725583e-01 | 0.429 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.725583e-01 | 0.429 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.775325e-01 | 0.321 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.775325e-01 | 0.321 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.775325e-01 | 0.321 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.775325e-01 | 0.321 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 1.308567e-01 | 0.883 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.471058e-01 | 0.607 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 2.868417e-01 | 0.542 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 3.383220e-01 | 0.471 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.383220e-01 | 0.471 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 3.383220e-01 | 0.471 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 3.383220e-01 | 0.471 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.383220e-01 | 0.471 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 3.383220e-01 | 0.471 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 3.383220e-01 | 0.471 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 3.383220e-01 | 0.471 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 1.614149e-01 | 0.792 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.672461e-01 | 0.573 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 2.672461e-01 | 0.573 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.819957e-01 | 0.740 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 3.108430e-01 | 0.507 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 3.108430e-01 | 0.507 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.104044e-01 | 0.387 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 4.104044e-01 | 0.387 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 2.877303e-01 | 0.541 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.877303e-01 | 0.541 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.877303e-01 | 0.541 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.468242e-01 | 0.833 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 2.069907e-01 | 0.684 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 3.675303e-01 | 0.435 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 3.675303e-01 | 0.435 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.951163e-01 | 0.710 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.500590e-01 | 0.602 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 2.342605e-01 | 0.630 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.350203e-01 | 0.475 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 2.199853e-01 | 0.658 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.084853e-01 | 0.511 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.859402e-01 | 0.544 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.645715e-01 | 0.784 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 3.294399e-01 | 0.482 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 3.294399e-01 | 0.482 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.294399e-01 | 0.482 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.592708e-01 | 0.445 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 3.592708e-01 | 0.445 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 4.470906e-01 | 0.350 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.470906e-01 | 0.350 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.470906e-01 | 0.350 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.470906e-01 | 0.350 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.470906e-01 | 0.350 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.230949e-01 | 0.491 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 3.230949e-01 | 0.491 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 3.834982e-01 | 0.416 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 3.834982e-01 | 0.416 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 3.834982e-01 | 0.416 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 2.890723e-01 | 0.539 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.251068e-01 | 0.372 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.076131e-01 | 0.390 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.824568e-01 | 0.317 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 4.824568e-01 | 0.317 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 4.824568e-01 | 0.317 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 4.824568e-01 | 0.317 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 3.416429e-01 | 0.466 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.416429e-01 | 0.466 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 4.532224e-01 | 0.344 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.532224e-01 | 0.344 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 4.315332e-01 | 0.365 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.348710e-01 | 0.475 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 4.807495e-01 | 0.318 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 4.556837e-01 | 0.341 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 4.221479e-01 | 0.375 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 4.221479e-01 | 0.375 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 4.221479e-01 | 0.375 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 4.384229e-01 | 0.358 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 4.721581e-01 | 0.326 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.721581e-01 | 0.326 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.891654e-01 | 0.311 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.891654e-01 | 0.311 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 1.371692e-01 | 0.863 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.809207e-01 | 0.318 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 3.230949e-01 | 0.491 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.455707e-01 | 0.837 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.735649e-01 | 0.761 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.632580e-01 | 0.787 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.613717e-01 | 0.583 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.150978e-01 | 0.667 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 4.684916e-01 | 0.329 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.471058e-01 | 0.607 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.505247e-01 | 0.455 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 2.978774e-01 | 0.526 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.779418e-01 | 0.423 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 3.105521e-01 | 0.508 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 3.530388e-01 | 0.452 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.702757e-01 | 0.328 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 1.822229e-01 | 0.739 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.984068e-01 | 0.702 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 3.044157e-01 | 0.517 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 1.700339e-01 | 0.769 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 1.894897e-01 | 0.722 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 3.350203e-01 | 0.475 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 4.384229e-01 | 0.358 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.213041e-01 | 0.655 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 4.382573e-01 | 0.358 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.672461e-01 | 0.573 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.928217e-01 | 0.406 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 3.044157e-01 | 0.517 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 3.099847e-01 | 0.509 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.972806e-01 | 0.527 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 2.868417e-01 | 0.542 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 4.104044e-01 | 0.387 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 4.251068e-01 | 0.372 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 2.086535e-01 | 0.681 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.798304e-01 | 0.553 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 4.104044e-01 | 0.387 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.672461e-01 | 0.573 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.104044e-01 | 0.387 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 4.367370e-01 | 0.360 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 1.984068e-01 | 0.702 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 3.420417e-01 | 0.466 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.273835e-01 | 0.643 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.273835e-01 | 0.643 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 4.344321e-01 | 0.362 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 4.344321e-01 | 0.362 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 4.344321e-01 | 0.362 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.759114e-01 | 0.755 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.679740e-01 | 0.775 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.943056e-01 | 0.531 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.498046e-01 | 0.602 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.500590e-01 | 0.602 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.350203e-01 | 0.475 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.592708e-01 | 0.445 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 3.965036e-01 | 0.402 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.743155e-01 | 0.759 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 1.371692e-01 | 0.863 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 2.859402e-01 | 0.544 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 3.185447e-01 | 0.497 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.859402e-01 | 0.544 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.393622e-01 | 0.856 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 4.134307e-01 | 0.384 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.382873e-01 | 0.859 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 2.943056e-01 | 0.531 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.948388e-01 | 0.710 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.725583e-01 | 0.429 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.775325e-01 | 0.321 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.342561e-01 | 0.872 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.877303e-01 | 0.541 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 3.716731e-01 | 0.430 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.824568e-01 | 0.317 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.861368e-01 | 0.313 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.115716e-01 | 0.506 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 1.646621e-01 | 0.783 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 4.824568e-01 | 0.317 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 3.798599e-01 | 0.420 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 4.001184e-01 | 0.398 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 3.903112e-01 | 0.409 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 4.204165e-01 | 0.376 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.877303e-01 | 0.541 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 2.413500e-01 | 0.617 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 4.824568e-01 | 0.317 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.261468e-01 | 0.899 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 2.471058e-01 | 0.607 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.348817e-01 | 0.362 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 3.928217e-01 | 0.406 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.663092e-01 | 0.779 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 1.568077e-01 | 0.805 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 2.242051e-01 | 0.649 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 1.759114e-01 | 0.755 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 1.333761e-01 | 0.875 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 2.170045e-01 | 0.664 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 3.090315e-01 | 0.510 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 3.090315e-01 | 0.510 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 2.868417e-01 | 0.542 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.383220e-01 | 0.471 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.383220e-01 | 0.471 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.498046e-01 | 0.602 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 3.108430e-01 | 0.507 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 4.470906e-01 | 0.350 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 2.995750e-01 | 0.523 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 4.139101e-01 | 0.383 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 4.139101e-01 | 0.383 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 3.080376e-01 | 0.511 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 2.681077e-01 | 0.572 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 3.412024e-01 | 0.467 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.607050e-01 | 0.584 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 3.165334e-01 | 0.500 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 3.926567e-01 | 0.406 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.393622e-01 | 0.856 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 2.607050e-01 | 0.584 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 4.315332e-01 | 0.365 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.420417e-01 | 0.466 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 4.472763e-01 | 0.349 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.529046e-01 | 0.816 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.371692e-01 | 0.863 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.743155e-01 | 0.759 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.592708e-01 | 0.445 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 1.423999e-01 | 0.846 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.148828e-01 | 0.668 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.337661e-01 | 0.477 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 3.090315e-01 | 0.510 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 2.868417e-01 | 0.542 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.468646e-01 | 0.608 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.658861e-01 | 0.575 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 4.551835e-01 | 0.342 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 4.122928e-01 | 0.385 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 1.923397e-01 | 0.716 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 2.398067e-01 | 0.620 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.471058e-01 | 0.607 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 1.642728e-01 | 0.784 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.545302e-01 | 0.594 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 2.545302e-01 | 0.594 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.631251e-01 | 0.580 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.109857e-01 | 0.507 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 4.139101e-01 | 0.383 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 2.509083e-01 | 0.600 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 3.725583e-01 | 0.429 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 1.435946e-01 | 0.843 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.740546e-01 | 0.759 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.784505e-01 | 0.555 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.250239e-01 | 0.648 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.383220e-01 | 0.471 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.750670e-01 | 0.561 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.476608e-01 | 0.831 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 3.303005e-01 | 0.481 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.528766e-01 | 0.452 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.941126e-01 | 0.531 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.945633e-01 | 0.711 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.945633e-01 | 0.711 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.512891e-01 | 0.454 | 0 | 0 |
| Neurophilin interactions with VEGF and VEGFR | R-HSA-194306 | 3.512891e-01 | 0.454 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.512891e-01 | 0.454 | 0 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.512891e-01 | 0.454 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 1.679740e-01 | 0.775 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.333761e-01 | 0.875 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 2.545302e-01 | 0.594 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 2.545302e-01 | 0.594 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.947485e-01 | 0.711 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 1.734318e-01 | 0.761 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.178208e-01 | 0.379 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 3.337661e-01 | 0.477 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 3.337661e-01 | 0.477 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 2.798304e-01 | 0.553 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.798304e-01 | 0.553 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 3.725583e-01 | 0.429 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 1.700339e-01 | 0.769 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 4.104044e-01 | 0.387 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 4.104044e-01 | 0.387 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.859402e-01 | 0.544 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.488958e-01 | 0.604 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.294399e-01 | 0.482 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 4.470906e-01 | 0.350 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 4.824568e-01 | 0.317 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 3.478835e-01 | 0.459 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 4.807495e-01 | 0.318 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 3.654812e-01 | 0.437 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 4.784962e-01 | 0.320 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 1.791163e-01 | 0.747 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.551835e-01 | 0.342 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.858842e-01 | 0.731 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 4.134943e-01 | 0.384 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 1.539407e-01 | 0.813 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.379649e-01 | 0.623 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.965036e-01 | 0.402 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.086405e-01 | 0.389 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 1.328366e-01 | 0.877 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 2.170045e-01 | 0.664 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 4.807495e-01 | 0.318 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 2.662996e-01 | 0.575 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.199853e-01 | 0.658 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.108430e-01 | 0.507 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.245643e-01 | 0.372 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.784505e-01 | 0.555 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.607050e-01 | 0.584 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 1.632580e-01 | 0.787 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.294097e-01 | 0.639 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.148828e-01 | 0.668 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 2.170045e-01 | 0.664 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.725583e-01 | 0.429 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 3.725583e-01 | 0.429 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.775325e-01 | 0.321 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.877303e-01 | 0.541 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 3.608653e-01 | 0.443 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 4.030288e-01 | 0.395 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 4.377546e-01 | 0.359 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 1.894897e-01 | 0.722 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.667938e-01 | 0.331 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 2.509083e-01 | 0.600 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.234308e-01 | 0.651 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.551835e-01 | 0.342 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 3.834982e-01 | 0.416 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 2.398067e-01 | 0.620 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.988658e-01 | 0.399 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 4.861368e-01 | 0.313 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.584529e-01 | 0.800 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.702757e-01 | 0.328 | 0 | 0 |
| Inhibition of membrane repair | R-HSA-9635644 | 2.771590e-01 | 0.557 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.512891e-01 | 0.454 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.545302e-01 | 0.594 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.725583e-01 | 0.429 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.775325e-01 | 0.321 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.775325e-01 | 0.321 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 4.104044e-01 | 0.387 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 2.677195e-01 | 0.572 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.419277e-01 | 0.466 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.824568e-01 | 0.317 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 4.824568e-01 | 0.317 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.139101e-01 | 0.383 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 4.139101e-01 | 0.383 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.641940e-01 | 0.439 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.784962e-01 | 0.320 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 3.505247e-01 | 0.455 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 4.784962e-01 | 0.320 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.108430e-01 | 0.507 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.135215e-01 | 0.384 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 1.886174e-01 | 0.724 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.545302e-01 | 0.594 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.344639e-01 | 0.871 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.614149e-01 | 0.792 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.747821e-01 | 0.561 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 2.681077e-01 | 0.572 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 4.762669e-01 | 0.322 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.326758e-01 | 0.633 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 4.702757e-01 | 0.328 | 1 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.684916e-01 | 0.329 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.948388e-01 | 0.710 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 1.376071e-01 | 0.861 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 2.638152e-01 | 0.579 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 3.898558e-01 | 0.409 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.948388e-01 | 0.710 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 3.337661e-01 | 0.477 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 2.341337e-01 | 0.631 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.509016e-01 | 0.455 | 1 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.532224e-01 | 0.344 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 3.898558e-01 | 0.409 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 3.675303e-01 | 0.435 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 3.730102e-01 | 0.428 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.679740e-01 | 0.775 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.177185e-01 | 0.379 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 4.532224e-01 | 0.344 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 4.470906e-01 | 0.350 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.943056e-01 | 0.531 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.081535e-01 | 0.682 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 2.185610e-01 | 0.660 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.470906e-01 | 0.350 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 3.035517e-01 | 0.518 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 4.556837e-01 | 0.341 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.189271e-01 | 0.496 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.721581e-01 | 0.326 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.556837e-01 | 0.341 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 4.104044e-01 | 0.387 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.675303e-01 | 0.435 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 4.251068e-01 | 0.372 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 1.399397e-01 | 0.854 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.714645e-01 | 0.766 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 4.139101e-01 | 0.383 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.303085e-01 | 0.366 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.104044e-01 | 0.387 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 4.315332e-01 | 0.365 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 4.892804e-01 | 0.310 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 4.925958e-01 | 0.308 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 4.965862e-01 | 0.304 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 4.982274e-01 | 0.303 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 4.982274e-01 | 0.303 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.989958e-01 | 0.302 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.014108e-01 | 0.300 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.014108e-01 | 0.300 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.014108e-01 | 0.300 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 5.014108e-01 | 0.300 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.014108e-01 | 0.300 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.018692e-01 | 0.299 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.018692e-01 | 0.299 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 5.021264e-01 | 0.299 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.060071e-01 | 0.296 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 5.076025e-01 | 0.294 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 5.076025e-01 | 0.294 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 5.108200e-01 | 0.292 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 5.108200e-01 | 0.292 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.111645e-01 | 0.291 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 5.144352e-01 | 0.289 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 5.162147e-01 | 0.287 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 5.162427e-01 | 0.287 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 5.163879e-01 | 0.287 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.163879e-01 | 0.287 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.163879e-01 | 0.287 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.163879e-01 | 0.287 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 5.163879e-01 | 0.287 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 5.163879e-01 | 0.287 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 5.163879e-01 | 0.287 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 5.163879e-01 | 0.287 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.163879e-01 | 0.287 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 5.163879e-01 | 0.287 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 5.163879e-01 | 0.287 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.166006e-01 | 0.287 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.226582e-01 | 0.282 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 5.226582e-01 | 0.282 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.226582e-01 | 0.282 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 5.227432e-01 | 0.282 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 5.238737e-01 | 0.281 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 5.238737e-01 | 0.281 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 5.238737e-01 | 0.281 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 5.238737e-01 | 0.281 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.238737e-01 | 0.281 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.238737e-01 | 0.281 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 5.239413e-01 | 0.281 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.274828e-01 | 0.278 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.287942e-01 | 0.277 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.287942e-01 | 0.277 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 5.287942e-01 | 0.277 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.287942e-01 | 0.277 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.311230e-01 | 0.275 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 5.311230e-01 | 0.275 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 5.311230e-01 | 0.275 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.311230e-01 | 0.275 | 0 | 0 |
| Activation of AKT2 | R-HSA-165158 | 5.311230e-01 | 0.275 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.311230e-01 | 0.275 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 5.311230e-01 | 0.275 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 5.311230e-01 | 0.275 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.311230e-01 | 0.275 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.311230e-01 | 0.275 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 5.337107e-01 | 0.273 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 5.337107e-01 | 0.273 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 5.337107e-01 | 0.273 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 5.337107e-01 | 0.273 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 5.362729e-01 | 0.271 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.390956e-01 | 0.268 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 5.390956e-01 | 0.268 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 5.390956e-01 | 0.268 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 5.396958e-01 | 0.268 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 5.407706e-01 | 0.267 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.464906e-01 | 0.262 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 5.480901e-01 | 0.261 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 5.488064e-01 | 0.261 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 5.488064e-01 | 0.261 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.488064e-01 | 0.261 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 5.488064e-01 | 0.261 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 5.488064e-01 | 0.261 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 5.541028e-01 | 0.256 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 5.552976e-01 | 0.255 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.555697e-01 | 0.255 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 5.561247e-01 | 0.255 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.561247e-01 | 0.255 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 5.574278e-01 | 0.254 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.589585e-01 | 0.253 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.589585e-01 | 0.253 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 5.590165e-01 | 0.253 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.631098e-01 | 0.249 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.631098e-01 | 0.249 | 1 | 0 |
| Kidney development | R-HSA-9830369 | 5.631098e-01 | 0.249 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 5.672644e-01 | 0.246 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 5.672644e-01 | 0.246 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 5.744614e-01 | 0.241 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 5.744614e-01 | 0.241 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 5.744614e-01 | 0.241 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.766112e-01 | 0.239 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 5.779082e-01 | 0.238 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.792195e-01 | 0.237 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.792195e-01 | 0.237 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.792195e-01 | 0.237 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.792195e-01 | 0.237 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.792195e-01 | 0.237 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.792195e-01 | 0.237 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 5.792195e-01 | 0.237 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 5.792195e-01 | 0.237 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 5.792195e-01 | 0.237 | 0 | 0 |
| Terminal pathway of complement | R-HSA-166665 | 5.792195e-01 | 0.237 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 5.792195e-01 | 0.237 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.792195e-01 | 0.237 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.792195e-01 | 0.237 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.792195e-01 | 0.237 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.792195e-01 | 0.237 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.792195e-01 | 0.237 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.792195e-01 | 0.237 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.792195e-01 | 0.237 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 5.792195e-01 | 0.237 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.796654e-01 | 0.237 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 5.796654e-01 | 0.237 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 5.796654e-01 | 0.237 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 5.796654e-01 | 0.237 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 5.796654e-01 | 0.237 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.796654e-01 | 0.237 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.809525e-01 | 0.236 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.809525e-01 | 0.236 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 5.834745e-01 | 0.234 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 5.834745e-01 | 0.234 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.834745e-01 | 0.234 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 5.869184e-01 | 0.231 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 5.883193e-01 | 0.230 | 1 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 5.929224e-01 | 0.227 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.976750e-01 | 0.224 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 6.023029e-01 | 0.220 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 6.023029e-01 | 0.220 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 6.023029e-01 | 0.220 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 6.060376e-01 | 0.218 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.067832e-01 | 0.217 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 6.067832e-01 | 0.217 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 6.067832e-01 | 0.217 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 6.070504e-01 | 0.217 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 6.083710e-01 | 0.216 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 6.083710e-01 | 0.216 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.089439e-01 | 0.215 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 6.089439e-01 | 0.215 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.089439e-01 | 0.215 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.089439e-01 | 0.215 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 6.089439e-01 | 0.215 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 6.089439e-01 | 0.215 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.089439e-01 | 0.215 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 6.106066e-01 | 0.214 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.109303e-01 | 0.214 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 6.180560e-01 | 0.209 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 6.188302e-01 | 0.208 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 6.193402e-01 | 0.208 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 6.206595e-01 | 0.207 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 6.208341e-01 | 0.207 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 6.208341e-01 | 0.207 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.220989e-01 | 0.206 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 6.223848e-01 | 0.206 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.223848e-01 | 0.206 | 0 | 0 |
| Chylomicron clearance | R-HSA-8964026 | 6.223848e-01 | 0.206 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.223848e-01 | 0.206 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.223848e-01 | 0.206 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 6.223848e-01 | 0.206 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 6.223848e-01 | 0.206 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.223848e-01 | 0.206 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 6.223848e-01 | 0.206 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.223848e-01 | 0.206 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.223848e-01 | 0.206 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.223848e-01 | 0.206 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 6.223848e-01 | 0.206 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.223848e-01 | 0.206 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 6.297201e-01 | 0.201 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 6.297201e-01 | 0.201 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 6.297201e-01 | 0.201 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 6.300137e-01 | 0.201 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 6.300137e-01 | 0.201 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 6.321468e-01 | 0.199 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 6.346123e-01 | 0.197 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 6.366413e-01 | 0.196 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.366413e-01 | 0.196 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 6.366413e-01 | 0.196 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 6.366413e-01 | 0.196 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 6.366413e-01 | 0.196 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 6.366413e-01 | 0.196 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 6.366413e-01 | 0.196 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 6.366413e-01 | 0.196 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 6.366413e-01 | 0.196 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 6.428567e-01 | 0.192 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.465818e-01 | 0.189 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 6.469898e-01 | 0.189 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 6.469898e-01 | 0.189 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 6.469898e-01 | 0.189 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.469898e-01 | 0.189 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.469898e-01 | 0.189 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 6.469898e-01 | 0.189 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.513881e-01 | 0.186 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 6.514681e-01 | 0.186 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 6.514681e-01 | 0.186 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 6.514681e-01 | 0.186 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 6.564789e-01 | 0.183 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 6.566549e-01 | 0.183 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 6.597485e-01 | 0.181 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.597485e-01 | 0.181 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 6.607845e-01 | 0.180 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.611243e-01 | 0.180 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 6.611243e-01 | 0.180 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to limit cholesterol uptake | R-HSA-9031525 | 6.611243e-01 | 0.180 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 6.611243e-01 | 0.180 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 6.611243e-01 | 0.180 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 6.611243e-01 | 0.180 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.611243e-01 | 0.180 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.611243e-01 | 0.180 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.611243e-01 | 0.180 | 0 | 0 |
| Mitochondrial ABC transporters | R-HSA-1369007 | 6.611243e-01 | 0.180 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 6.611243e-01 | 0.180 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 6.611243e-01 | 0.180 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 6.611243e-01 | 0.180 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.611243e-01 | 0.180 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.611243e-01 | 0.180 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 6.620633e-01 | 0.179 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 6.620633e-01 | 0.179 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 6.627739e-01 | 0.179 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 6.627739e-01 | 0.179 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 6.627739e-01 | 0.179 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.627739e-01 | 0.179 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.627739e-01 | 0.179 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 6.627739e-01 | 0.179 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 6.627739e-01 | 0.179 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.627739e-01 | 0.179 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.714203e-01 | 0.173 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 6.722869e-01 | 0.172 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 6.737188e-01 | 0.172 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 6.742189e-01 | 0.171 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.781020e-01 | 0.169 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 6.829330e-01 | 0.166 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.829988e-01 | 0.166 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 6.829988e-01 | 0.166 | 1 | 1 |
| CaM pathway | R-HSA-111997 | 6.829988e-01 | 0.166 | 1 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 6.830940e-01 | 0.166 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 6.865521e-01 | 0.163 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 6.866390e-01 | 0.163 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.873712e-01 | 0.163 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.873712e-01 | 0.163 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 6.873712e-01 | 0.163 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.873712e-01 | 0.163 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.873712e-01 | 0.163 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.908317e-01 | 0.161 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 6.921758e-01 | 0.160 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 6.921758e-01 | 0.160 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.958916e-01 | 0.157 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.958916e-01 | 0.157 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.958916e-01 | 0.157 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.958916e-01 | 0.157 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.958916e-01 | 0.157 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.958916e-01 | 0.157 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 6.958916e-01 | 0.157 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.958916e-01 | 0.157 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.958916e-01 | 0.157 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.958916e-01 | 0.157 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 6.958916e-01 | 0.157 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 6.991118e-01 | 0.155 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 7.000058e-01 | 0.155 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 7.012123e-01 | 0.154 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 7.054652e-01 | 0.152 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.084349e-01 | 0.150 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.084349e-01 | 0.150 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 7.086250e-01 | 0.150 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 7.086250e-01 | 0.150 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 7.104731e-01 | 0.148 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 7.104731e-01 | 0.148 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.104731e-01 | 0.148 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 7.104731e-01 | 0.148 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 7.104731e-01 | 0.148 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 7.104731e-01 | 0.148 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 7.110890e-01 | 0.148 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.111404e-01 | 0.148 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 7.165039e-01 | 0.145 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 7.193506e-01 | 0.143 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.197336e-01 | 0.143 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 7.227487e-01 | 0.141 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 7.231027e-01 | 0.141 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.270938e-01 | 0.138 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.270938e-01 | 0.138 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.270938e-01 | 0.138 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.270938e-01 | 0.138 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.270938e-01 | 0.138 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.270938e-01 | 0.138 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.270938e-01 | 0.138 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.270938e-01 | 0.138 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.270938e-01 | 0.138 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 7.270938e-01 | 0.138 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.270938e-01 | 0.138 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.270938e-01 | 0.138 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 7.270938e-01 | 0.138 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.278200e-01 | 0.138 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.301822e-01 | 0.137 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 7.320200e-01 | 0.135 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 7.321275e-01 | 0.135 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 7.321275e-01 | 0.135 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.321275e-01 | 0.135 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 7.321275e-01 | 0.135 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 7.321275e-01 | 0.135 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 7.321275e-01 | 0.135 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 7.321275e-01 | 0.135 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.321275e-01 | 0.135 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.340888e-01 | 0.134 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 7.361889e-01 | 0.133 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 7.362897e-01 | 0.133 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 7.371614e-01 | 0.132 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.397864e-01 | 0.131 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.397864e-01 | 0.131 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.397864e-01 | 0.131 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.410639e-01 | 0.130 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 7.420149e-01 | 0.130 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 7.430226e-01 | 0.129 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 7.430226e-01 | 0.129 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 7.430226e-01 | 0.129 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 7.430226e-01 | 0.129 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 7.430226e-01 | 0.129 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 7.470347e-01 | 0.127 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.470347e-01 | 0.127 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.470347e-01 | 0.127 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 7.470347e-01 | 0.127 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.470347e-01 | 0.127 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.493614e-01 | 0.125 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.522106e-01 | 0.124 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 7.523882e-01 | 0.124 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 7.523882e-01 | 0.124 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 7.523882e-01 | 0.124 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 7.523882e-01 | 0.124 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.523882e-01 | 0.124 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.550962e-01 | 0.122 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 7.550962e-01 | 0.122 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.550962e-01 | 0.122 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 7.550962e-01 | 0.122 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.626156e-01 | 0.118 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.626156e-01 | 0.118 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.634062e-01 | 0.117 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 7.669958e-01 | 0.115 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 7.713131e-01 | 0.113 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.713131e-01 | 0.113 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.713131e-01 | 0.113 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 7.718869e-01 | 0.112 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.723919e-01 | 0.112 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.723919e-01 | 0.112 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.751175e-01 | 0.111 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 7.751175e-01 | 0.111 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.751175e-01 | 0.111 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.758098e-01 | 0.110 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 7.783420e-01 | 0.109 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 7.783420e-01 | 0.109 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.802268e-01 | 0.108 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.802268e-01 | 0.108 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.802268e-01 | 0.108 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.802268e-01 | 0.108 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.802268e-01 | 0.108 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.802268e-01 | 0.108 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.802268e-01 | 0.108 | 0 | 0 |
| Prostanoid ligand receptors | R-HSA-391908 | 7.802268e-01 | 0.108 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.818773e-01 | 0.107 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 7.821195e-01 | 0.107 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 7.882075e-01 | 0.103 | 1 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.889630e-01 | 0.103 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 7.889630e-01 | 0.103 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 7.889630e-01 | 0.103 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 7.889630e-01 | 0.103 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.891920e-01 | 0.103 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 7.892667e-01 | 0.103 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.903779e-01 | 0.102 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.926102e-01 | 0.101 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.965638e-01 | 0.099 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.965638e-01 | 0.099 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 7.997753e-01 | 0.097 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 8.017435e-01 | 0.096 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.027800e-01 | 0.095 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.027800e-01 | 0.095 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.027800e-01 | 0.095 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.027800e-01 | 0.095 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 8.027800e-01 | 0.095 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 8.027800e-01 | 0.095 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 8.027800e-01 | 0.095 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 8.027800e-01 | 0.095 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 8.027800e-01 | 0.095 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.041949e-01 | 0.095 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 8.049410e-01 | 0.094 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 8.054002e-01 | 0.094 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 8.054002e-01 | 0.094 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 8.054002e-01 | 0.094 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.054002e-01 | 0.094 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 8.054002e-01 | 0.094 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.063833e-01 | 0.093 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.063833e-01 | 0.093 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.117975e-01 | 0.091 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 8.125525e-01 | 0.090 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.125525e-01 | 0.090 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.193771e-01 | 0.087 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 8.193771e-01 | 0.087 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.201978e-01 | 0.086 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 8.206877e-01 | 0.086 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.206877e-01 | 0.086 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 8.206877e-01 | 0.086 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 8.206877e-01 | 0.086 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 8.206877e-01 | 0.086 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.206877e-01 | 0.086 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.206877e-01 | 0.086 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 8.230199e-01 | 0.085 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 8.230199e-01 | 0.085 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.230199e-01 | 0.085 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.230199e-01 | 0.085 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 8.230199e-01 | 0.085 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.230199e-01 | 0.085 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 8.238386e-01 | 0.084 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.316205e-01 | 0.080 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.316205e-01 | 0.080 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 8.339465e-01 | 0.079 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.345563e-01 | 0.079 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 8.348883e-01 | 0.078 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.348883e-01 | 0.078 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.348883e-01 | 0.078 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 8.348883e-01 | 0.078 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.372832e-01 | 0.077 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.378701e-01 | 0.077 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.410159e-01 | 0.075 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.411838e-01 | 0.075 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 8.411838e-01 | 0.075 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 8.411838e-01 | 0.075 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.411838e-01 | 0.075 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.411838e-01 | 0.075 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.411838e-01 | 0.075 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.411838e-01 | 0.075 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 8.431436e-01 | 0.074 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.431436e-01 | 0.074 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 8.463166e-01 | 0.072 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 8.473519e-01 | 0.072 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 8.480639e-01 | 0.072 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 8.480639e-01 | 0.072 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 8.480639e-01 | 0.072 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 8.480639e-01 | 0.072 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.480951e-01 | 0.072 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 8.485413e-01 | 0.071 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 8.490054e-01 | 0.071 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.533313e-01 | 0.069 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 8.539765e-01 | 0.069 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 8.539765e-01 | 0.069 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 8.541132e-01 | 0.068 | 1 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.543587e-01 | 0.068 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 8.574844e-01 | 0.067 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.574844e-01 | 0.067 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.574844e-01 | 0.067 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 8.574844e-01 | 0.067 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.574844e-01 | 0.067 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.574844e-01 | 0.067 | 0 | 0 |
| Formation of the active cofactor, UDP-glucuronate | R-HSA-173599 | 8.574844e-01 | 0.067 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 8.602755e-01 | 0.065 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 8.602755e-01 | 0.065 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 8.602755e-01 | 0.065 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 8.602755e-01 | 0.065 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.602755e-01 | 0.065 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.602755e-01 | 0.065 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 8.641497e-01 | 0.063 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 8.658659e-01 | 0.063 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.665817e-01 | 0.062 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.669703e-01 | 0.062 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 8.675573e-01 | 0.062 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 8.715819e-01 | 0.060 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.721128e-01 | 0.059 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.721128e-01 | 0.059 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.721128e-01 | 0.059 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.721128e-01 | 0.059 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.721128e-01 | 0.059 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.721128e-01 | 0.059 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.721128e-01 | 0.059 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.721128e-01 | 0.059 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.736938e-01 | 0.059 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 8.736938e-01 | 0.059 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.802621e-01 | 0.055 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 8.820403e-01 | 0.055 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.820403e-01 | 0.055 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 8.820403e-01 | 0.055 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 8.826389e-01 | 0.054 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.826389e-01 | 0.054 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 8.826389e-01 | 0.054 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 8.826389e-01 | 0.054 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 8.826389e-01 | 0.054 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.836468e-01 | 0.054 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.852405e-01 | 0.053 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.852405e-01 | 0.053 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 8.852405e-01 | 0.053 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.852405e-01 | 0.053 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.852405e-01 | 0.053 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.876357e-01 | 0.052 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.879600e-01 | 0.052 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 8.894534e-01 | 0.051 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 8.894534e-01 | 0.051 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 8.894534e-01 | 0.051 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 8.901150e-01 | 0.051 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 8.910148e-01 | 0.050 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 8.945078e-01 | 0.048 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 8.945078e-01 | 0.048 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.952218e-01 | 0.048 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.970213e-01 | 0.047 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.970213e-01 | 0.047 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.970213e-01 | 0.047 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.970213e-01 | 0.047 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 8.970213e-01 | 0.047 | 0 | 0 |
| Heme assimilation | R-HSA-9927020 | 8.970213e-01 | 0.047 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 8.970213e-01 | 0.047 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.970213e-01 | 0.047 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.970213e-01 | 0.047 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.976798e-01 | 0.047 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.976798e-01 | 0.047 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.988508e-01 | 0.046 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 8.988508e-01 | 0.046 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.988508e-01 | 0.046 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.988508e-01 | 0.046 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 8.988508e-01 | 0.046 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.988508e-01 | 0.046 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.988508e-01 | 0.046 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 8.993921e-01 | 0.046 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.994080e-01 | 0.046 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.005995e-01 | 0.045 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.006305e-01 | 0.045 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.006305e-01 | 0.045 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.017553e-01 | 0.045 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 9.020665e-01 | 0.045 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.021369e-01 | 0.045 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.032101e-01 | 0.044 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.061975e-01 | 0.043 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.071967e-01 | 0.042 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.075934e-01 | 0.042 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 9.075934e-01 | 0.042 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.075934e-01 | 0.042 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.075934e-01 | 0.042 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.075934e-01 | 0.042 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 9.088650e-01 | 0.042 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.088650e-01 | 0.042 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.088650e-01 | 0.042 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 9.125606e-01 | 0.040 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.130160e-01 | 0.040 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.130160e-01 | 0.040 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.142522e-01 | 0.039 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.161362e-01 | 0.038 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.164567e-01 | 0.038 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 9.164567e-01 | 0.038 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 9.170806e-01 | 0.038 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 9.170806e-01 | 0.038 | 0 | 0 |
| PKA activation | R-HSA-163615 | 9.170806e-01 | 0.038 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.170806e-01 | 0.038 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.171506e-01 | 0.038 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.180415e-01 | 0.037 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.185377e-01 | 0.037 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 9.228173e-01 | 0.035 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 9.234509e-01 | 0.035 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.253531e-01 | 0.034 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.253531e-01 | 0.034 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.253531e-01 | 0.034 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.253531e-01 | 0.034 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.253531e-01 | 0.034 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.255943e-01 | 0.034 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.255943e-01 | 0.034 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 9.255943e-01 | 0.034 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.255943e-01 | 0.034 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 9.255943e-01 | 0.034 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.255943e-01 | 0.034 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.255943e-01 | 0.034 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.278845e-01 | 0.033 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 9.281336e-01 | 0.032 | 1 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.286486e-01 | 0.032 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 9.292432e-01 | 0.032 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 9.298901e-01 | 0.032 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.298901e-01 | 0.032 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 9.309004e-01 | 0.031 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.326967e-01 | 0.030 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.332343e-01 | 0.030 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.332343e-01 | 0.030 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.332343e-01 | 0.030 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.332343e-01 | 0.030 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 9.332343e-01 | 0.030 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.358146e-01 | 0.029 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.358146e-01 | 0.029 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.358146e-01 | 0.029 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.398322e-01 | 0.027 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.400903e-01 | 0.027 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.400903e-01 | 0.027 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 9.400903e-01 | 0.027 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.400903e-01 | 0.027 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.400903e-01 | 0.027 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.400903e-01 | 0.027 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.412621e-01 | 0.026 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.433160e-01 | 0.025 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.441208e-01 | 0.025 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.456166e-01 | 0.024 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 9.460796e-01 | 0.024 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.462426e-01 | 0.024 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.462426e-01 | 0.024 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.462426e-01 | 0.024 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 9.462681e-01 | 0.024 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.462681e-01 | 0.024 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.462681e-01 | 0.024 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.462681e-01 | 0.024 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 9.466520e-01 | 0.024 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.484957e-01 | 0.023 | 1 | 1 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.508657e-01 | 0.022 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.517634e-01 | 0.021 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.517634e-01 | 0.021 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.533544e-01 | 0.021 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 9.550862e-01 | 0.020 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 9.552738e-01 | 0.020 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.567175e-01 | 0.019 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.567175e-01 | 0.019 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.567408e-01 | 0.019 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 9.569356e-01 | 0.019 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.569356e-01 | 0.019 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.589583e-01 | 0.018 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.589583e-01 | 0.018 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.589583e-01 | 0.018 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.595668e-01 | 0.018 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.611631e-01 | 0.017 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.611631e-01 | 0.017 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.611631e-01 | 0.017 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.611631e-01 | 0.017 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.625091e-01 | 0.017 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.625091e-01 | 0.017 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.640528e-01 | 0.016 | 0 | 0 |
| Beta-oxidation of pristanoyl-CoA | R-HSA-389887 | 9.651523e-01 | 0.015 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.651523e-01 | 0.015 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.651523e-01 | 0.015 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.657638e-01 | 0.015 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.657638e-01 | 0.015 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.657638e-01 | 0.015 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.657638e-01 | 0.015 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.657638e-01 | 0.015 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 9.687320e-01 | 0.014 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.687320e-01 | 0.014 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.701584e-01 | 0.013 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.711117e-01 | 0.013 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.714765e-01 | 0.013 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.714765e-01 | 0.013 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.714765e-01 | 0.013 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.714765e-01 | 0.013 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.719441e-01 | 0.012 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.719441e-01 | 0.012 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.719441e-01 | 0.012 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 9.719441e-01 | 0.012 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.719441e-01 | 0.012 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.719441e-01 | 0.012 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.732127e-01 | 0.012 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 9.742277e-01 | 0.011 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.748264e-01 | 0.011 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.748264e-01 | 0.011 | 0 | 0 |
| Iron assimilation using enterobactin | R-HSA-9638334 | 9.748264e-01 | 0.011 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.748264e-01 | 0.011 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 9.748264e-01 | 0.011 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.756426e-01 | 0.011 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.762637e-01 | 0.010 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.762637e-01 | 0.010 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.762637e-01 | 0.010 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.762637e-01 | 0.010 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.762663e-01 | 0.010 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.767056e-01 | 0.010 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.771644e-01 | 0.010 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.774128e-01 | 0.010 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.774128e-01 | 0.010 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 9.775787e-01 | 0.010 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.775787e-01 | 0.010 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.783559e-01 | 0.010 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 9.783559e-01 | 0.010 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.783559e-01 | 0.010 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 9.790865e-01 | 0.009 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.797336e-01 | 0.009 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.800641e-01 | 0.009 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.802690e-01 | 0.009 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.802690e-01 | 0.009 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.806094e-01 | 0.009 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.812074e-01 | 0.008 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.816664e-01 | 0.008 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.820176e-01 | 0.008 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.830949e-01 | 0.007 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.830949e-01 | 0.007 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.836153e-01 | 0.007 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.836846e-01 | 0.007 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.836846e-01 | 0.007 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.841472e-01 | 0.007 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.847789e-01 | 0.007 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.850747e-01 | 0.007 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.850747e-01 | 0.007 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.852517e-01 | 0.006 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 9.854617e-01 | 0.006 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.858816e-01 | 0.006 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.864072e-01 | 0.006 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.864492e-01 | 0.006 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.868657e-01 | 0.006 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 9.868657e-01 | 0.006 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.868657e-01 | 0.006 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.868657e-01 | 0.006 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.868657e-01 | 0.006 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.875450e-01 | 0.005 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.876236e-01 | 0.005 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.876236e-01 | 0.005 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 9.879062e-01 | 0.005 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.882156e-01 | 0.005 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.882156e-01 | 0.005 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.882156e-01 | 0.005 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.882156e-01 | 0.005 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.882156e-01 | 0.005 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 9.885700e-01 | 0.005 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.893450e-01 | 0.005 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.894268e-01 | 0.005 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.899708e-01 | 0.004 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.905137e-01 | 0.004 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.906700e-01 | 0.004 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.909131e-01 | 0.004 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.914888e-01 | 0.004 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.914888e-01 | 0.004 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.914888e-01 | 0.004 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.914888e-01 | 0.004 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.914888e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.914888e-01 | 0.004 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.914888e-01 | 0.004 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.915122e-01 | 0.004 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.915122e-01 | 0.004 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.922854e-01 | 0.003 | 0 | 0 |
| tRNA processing in the mitochondrion | R-HSA-6785470 | 9.923638e-01 | 0.003 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.923638e-01 | 0.003 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.923638e-01 | 0.003 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.923638e-01 | 0.003 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.929794e-01 | 0.003 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.934865e-01 | 0.003 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.938532e-01 | 0.003 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.938532e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.939948e-01 | 0.003 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.941974e-01 | 0.003 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.944347e-01 | 0.002 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.944347e-01 | 0.002 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.945428e-01 | 0.002 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.947262e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.947540e-01 | 0.002 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.950523e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.951945e-01 | 0.002 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.952075e-01 | 0.002 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.953008e-01 | 0.002 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.955611e-01 | 0.002 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.955611e-01 | 0.002 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 9.955611e-01 | 0.002 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.955991e-01 | 0.002 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.956718e-01 | 0.002 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.960176e-01 | 0.002 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.963001e-01 | 0.002 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.963564e-01 | 0.002 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.964074e-01 | 0.002 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.964271e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.964271e-01 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.965999e-01 | 0.001 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.966227e-01 | 0.001 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.967946e-01 | 0.001 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.969108e-01 | 0.001 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.971243e-01 | 0.001 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 9.973003e-01 | 0.001 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 9.973003e-01 | 0.001 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.974201e-01 | 0.001 | 0 | 0 |
| Metal ion assimilation from the host | R-HSA-9638482 | 9.981758e-01 | 0.001 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 9.981940e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.983289e-01 | 0.001 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.983289e-01 | 0.001 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 9.986226e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.986551e-01 | 0.001 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 9.987419e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.987710e-01 | 0.001 | 1 | 1 |
| Platelet homeostasis | R-HSA-418346 | 9.987718e-01 | 0.001 | 0 | 0 |
| Glucuronidation | R-HSA-156588 | 9.987935e-01 | 0.001 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.988511e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.989176e-01 | 0.000 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.990290e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.990424e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.990618e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.990799e-01 | 0.000 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 9.991259e-01 | 0.000 | 0 | 0 |
| Scavenging of heme from plasma | R-HSA-2168880 | 9.992023e-01 | 0.000 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.992186e-01 | 0.000 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.992341e-01 | 0.000 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.993150e-01 | 0.000 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.993712e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.994359e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.994940e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.995165e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.995466e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.995636e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.995636e-01 | 0.000 | 0 | 0 |
| Classical antibody-mediated complement activation | R-HSA-173623 | 9.996896e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.997039e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.997061e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997061e-01 | 0.000 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.997061e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.997364e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.997399e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.997879e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.998097e-01 | 0.000 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.998097e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.998097e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.998469e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.998469e-01 | 0.000 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 9.998736e-01 | 0.000 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.998736e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.998768e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999153e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.999203e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999225e-01 | 0.000 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 9.999308e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.999359e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999372e-01 | 0.000 | 1 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.999434e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.999467e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.999537e-01 | 0.000 | 0 | 0 |
| Creation of C4 and C2 activators | R-HSA-166786 | 9.999622e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999638e-01 | 0.000 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 9.999658e-01 | 0.000 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.999666e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999748e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999772e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999784e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999826e-01 | 0.000 | 0 | 0 |
| Initial triggering of complement | R-HSA-166663 | 9.999848e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999858e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.999864e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.999875e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999910e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.999910e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999927e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999952e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999958e-01 | 0.000 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.999961e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.999962e-01 | 0.000 | 1 | 0 |
| Complement cascade | R-HSA-166658 | 9.999964e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999972e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999978e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999980e-01 | 0.000 | 1 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999980e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999982e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999986e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999988e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999990e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999993e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999996e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999996e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999997e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999997e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999998e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | -0.000 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 1.000000e+00 | 0.000 | 1 | 1 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Metabolism of RNA | R-HSA-8953854 | 4.873879e-14 | 13.312 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 6.140644e-13 | 12.212 | 0 | 0 |
| M Phase | R-HSA-68886 | 1.214031e-09 | 8.916 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.298214e-09 | 8.887 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.328086e-08 | 7.877 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.194706e-08 | 7.659 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 3.714932e-08 | 7.430 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 4.414627e-08 | 7.355 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.984317e-08 | 7.302 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 6.853958e-08 | 7.164 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 7.758163e-08 | 7.110 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.005918e-07 | 6.997 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.523004e-07 | 6.817 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.683155e-07 | 6.774 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 3.835753e-07 | 6.416 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.687057e-07 | 6.175 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.193437e-06 | 5.923 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.334707e-06 | 5.632 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.974202e-06 | 5.527 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.001070e-06 | 5.523 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.306688e-06 | 5.481 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.583944e-06 | 5.339 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.583944e-06 | 5.339 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 5.420450e-06 | 5.266 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 7.862789e-06 | 5.104 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 8.480689e-06 | 5.072 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 9.831288e-06 | 5.007 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 1.092251e-05 | 4.962 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.283681e-05 | 4.892 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.906980e-05 | 4.720 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 2.585165e-05 | 4.588 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 2.446239e-05 | 4.612 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 2.747012e-05 | 4.561 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 2.722044e-05 | 4.565 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.643745e-05 | 4.578 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 2.757329e-05 | 4.560 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 3.024692e-05 | 4.519 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 3.024692e-05 | 4.519 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.631493e-05 | 4.440 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.701756e-05 | 4.432 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 4.039079e-05 | 4.394 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.482667e-05 | 4.348 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.417469e-05 | 4.355 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 5.028616e-05 | 4.299 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 5.584147e-05 | 4.253 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 6.284947e-05 | 4.202 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 7.048490e-05 | 4.152 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 7.381537e-05 | 4.132 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.553537e-05 | 4.020 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 9.752691e-05 | 4.011 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.022202e-04 | 3.990 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.547825e-04 | 3.810 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 1.806961e-04 | 3.743 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.806961e-04 | 3.743 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 1.826079e-04 | 3.738 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 1.850876e-04 | 3.733 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.340025e-04 | 3.631 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.265474e-04 | 3.645 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 2.311067e-04 | 3.636 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 2.420802e-04 | 3.616 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.460354e-04 | 3.609 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 2.747287e-04 | 3.561 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.747287e-04 | 3.561 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 2.698904e-04 | 3.569 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.715956e-04 | 3.566 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 2.910468e-04 | 3.536 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.833938e-04 | 3.548 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 3.403296e-04 | 3.468 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 3.369518e-04 | 3.472 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 3.519593e-04 | 3.454 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.643303e-04 | 3.439 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.579200e-04 | 3.446 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 3.646973e-04 | 3.438 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 3.646973e-04 | 3.438 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.786367e-04 | 3.422 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 4.027694e-04 | 3.395 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 3.877921e-04 | 3.411 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.058240e-04 | 3.392 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 4.180615e-04 | 3.379 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.480172e-04 | 3.349 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.561977e-04 | 3.341 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 4.657521e-04 | 3.332 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.947207e-04 | 3.306 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.826986e-04 | 3.316 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 4.947207e-04 | 3.306 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 5.273788e-04 | 3.278 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 5.279998e-04 | 3.277 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 5.285559e-04 | 3.277 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 6.106097e-04 | 3.214 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.703226e-04 | 3.174 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 6.716859e-04 | 3.173 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.249957e-04 | 3.140 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.475297e-04 | 3.072 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 8.553411e-04 | 3.068 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.754839e-04 | 3.058 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.452904e-04 | 3.024 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 8.961221e-04 | 3.048 | 1 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.811756e-04 | 3.008 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.811756e-04 | 3.008 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.007412e-03 | 2.997 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.014073e-03 | 2.994 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.584140e-04 | 3.018 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 1.016708e-03 | 2.993 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.035100e-03 | 2.985 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.052876e-03 | 2.978 | 0 | 0 |
| S Phase | R-HSA-69242 | 1.084618e-03 | 2.965 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.158165e-03 | 2.936 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.158165e-03 | 2.936 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 1.163615e-03 | 2.934 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.163615e-03 | 2.934 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.294424e-03 | 2.888 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 1.256441e-03 | 2.901 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.309934e-03 | 2.883 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 1.377004e-03 | 2.861 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 1.425404e-03 | 2.846 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 1.425404e-03 | 2.846 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 1.475733e-03 | 2.831 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.599497e-03 | 2.796 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.599497e-03 | 2.796 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 1.515276e-03 | 2.820 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.509248e-03 | 2.821 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 1.515276e-03 | 2.820 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 1.651935e-03 | 2.782 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.679951e-03 | 2.775 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.681288e-03 | 2.774 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.681288e-03 | 2.774 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.703239e-03 | 2.769 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.806764e-03 | 2.743 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.816182e-03 | 2.741 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.006109e-03 | 2.698 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.932907e-03 | 2.714 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.006109e-03 | 2.698 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 1.973239e-03 | 2.705 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.010134e-03 | 2.697 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.162179e-03 | 2.665 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.162179e-03 | 2.665 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.283629e-03 | 2.641 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.303284e-03 | 2.638 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.332329e-03 | 2.632 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 2.371809e-03 | 2.625 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 2.371809e-03 | 2.625 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 2.371809e-03 | 2.625 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.537723e-03 | 2.596 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 2.537723e-03 | 2.596 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.666462e-03 | 2.574 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 2.666462e-03 | 2.574 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 2.684693e-03 | 2.571 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.893475e-03 | 2.539 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 2.914962e-03 | 2.535 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.994785e-03 | 2.524 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 3.020692e-03 | 2.520 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 3.021969e-03 | 2.520 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 3.089020e-03 | 2.510 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.124928e-03 | 2.505 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 3.158594e-03 | 2.501 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 3.368038e-03 | 2.473 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 3.540317e-03 | 2.451 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 3.540317e-03 | 2.451 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.540317e-03 | 2.451 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.247391e-03 | 2.488 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 3.247391e-03 | 2.488 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.543289e-03 | 2.451 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.588606e-03 | 2.445 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.588606e-03 | 2.445 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.588606e-03 | 2.445 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.588606e-03 | 2.445 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 3.654693e-03 | 2.437 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.830529e-03 | 2.417 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.830529e-03 | 2.417 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.108437e-03 | 2.386 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 4.756840e-03 | 2.323 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.704575e-03 | 2.327 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.545227e-03 | 2.342 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.444334e-03 | 2.352 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 4.343630e-03 | 2.362 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 4.649207e-03 | 2.333 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 4.850087e-03 | 2.314 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 4.954782e-03 | 2.305 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 4.954782e-03 | 2.305 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 5.261446e-03 | 2.279 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 5.691172e-03 | 2.245 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 5.691172e-03 | 2.245 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 5.723926e-03 | 2.242 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 5.821962e-03 | 2.235 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 5.821962e-03 | 2.235 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 5.821962e-03 | 2.235 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.865174e-03 | 2.232 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.240867e-03 | 2.205 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 6.317746e-03 | 2.199 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 6.317746e-03 | 2.199 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.317746e-03 | 2.199 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.320815e-03 | 2.135 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 6.989517e-03 | 2.156 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 6.511947e-03 | 2.186 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.320815e-03 | 2.135 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 7.182929e-03 | 2.144 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 7.182929e-03 | 2.144 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.464755e-03 | 2.189 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 6.493268e-03 | 2.188 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 7.320815e-03 | 2.135 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 7.320815e-03 | 2.135 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.348810e-03 | 2.134 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 7.354412e-03 | 2.133 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 7.648519e-03 | 2.116 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 7.896594e-03 | 2.103 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 8.196385e-03 | 2.086 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 8.317217e-03 | 2.080 | 0 | 0 |
| Kinesins | R-HSA-983189 | 8.413088e-03 | 2.075 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.526283e-03 | 2.069 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 8.526283e-03 | 2.069 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 8.526283e-03 | 2.069 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 8.605611e-03 | 2.065 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.748744e-03 | 2.058 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 8.989487e-03 | 2.046 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 8.989487e-03 | 2.046 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 8.989487e-03 | 2.046 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.018985e-02 | 1.992 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.018985e-02 | 1.992 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.018985e-02 | 1.992 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 9.263042e-03 | 2.033 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 9.801167e-03 | 2.009 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 9.509969e-03 | 2.022 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 1.002838e-02 | 1.999 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 9.292911e-03 | 2.032 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.011171e-02 | 1.995 | 1 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 1.077633e-02 | 1.968 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 9.801167e-03 | 2.009 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.087619e-02 | 1.964 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 1.087619e-02 | 1.964 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 1.130792e-02 | 1.947 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 1.130792e-02 | 1.947 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 1.135211e-02 | 1.945 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.135211e-02 | 1.945 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.154758e-02 | 1.938 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 1.154758e-02 | 1.938 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.154758e-02 | 1.938 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 1.161671e-02 | 1.935 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.180695e-02 | 1.928 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.219142e-02 | 1.914 | 1 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 1.240247e-02 | 1.906 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 1.240247e-02 | 1.906 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.262860e-02 | 1.899 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.272821e-02 | 1.895 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 1.287868e-02 | 1.890 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 1.293370e-02 | 1.888 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.293370e-02 | 1.888 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.373989e-02 | 1.862 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis Due to p14ARF Loss of Function | R-HSA-9645722 | 1.373989e-02 | 1.862 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.443800e-02 | 1.840 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.443800e-02 | 1.840 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.443800e-02 | 1.840 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 1.443800e-02 | 1.840 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 1.351797e-02 | 1.869 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.584590e-02 | 1.800 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 1.433478e-02 | 1.844 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.369222e-02 | 1.864 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 1.373507e-02 | 1.862 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 1.443800e-02 | 1.840 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 1.533905e-02 | 1.814 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 1.460794e-02 | 1.835 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.327380e-02 | 1.877 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.332620e-02 | 1.875 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 1.533429e-02 | 1.814 | 1 | 1 |
| ESR-mediated signaling | R-HSA-8939211 | 1.412889e-02 | 1.850 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.510041e-02 | 1.821 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.572031e-02 | 1.804 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 1.645085e-02 | 1.784 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 1.651428e-02 | 1.782 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.696797e-02 | 1.770 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 1.696797e-02 | 1.770 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.696797e-02 | 1.770 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 1.696797e-02 | 1.770 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 1.696797e-02 | 1.770 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 1.704549e-02 | 1.768 | 1 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.705482e-02 | 1.768 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.725620e-02 | 1.763 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 1.725620e-02 | 1.763 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 1.725620e-02 | 1.763 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.726009e-02 | 1.763 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.749843e-02 | 1.757 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.817101e-02 | 1.741 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.822498e-02 | 1.739 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.822498e-02 | 1.739 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 1.913507e-02 | 1.718 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.913507e-02 | 1.718 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 1.930691e-02 | 1.714 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.975106e-02 | 1.704 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.003940e-02 | 1.698 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 2.073239e-02 | 1.683 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.460272e-02 | 1.609 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 2.460272e-02 | 1.609 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 2.460272e-02 | 1.609 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.460272e-02 | 1.609 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.246146e-02 | 1.649 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 2.246146e-02 | 1.649 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.246146e-02 | 1.649 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 2.261431e-02 | 1.646 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 2.465443e-02 | 1.608 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.465443e-02 | 1.608 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.133373e-02 | 1.671 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.133373e-02 | 1.671 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 2.476748e-02 | 1.606 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.603473e-02 | 1.584 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.553349e-02 | 1.593 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 2.088377e-02 | 1.680 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 2.083622e-02 | 1.681 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 2.476748e-02 | 1.606 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.261431e-02 | 1.646 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 2.510170e-02 | 1.600 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 2.083622e-02 | 1.681 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.261996e-02 | 1.646 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.133373e-02 | 1.671 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 2.307006e-02 | 1.637 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 2.518631e-02 | 1.599 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.088377e-02 | 1.680 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.529897e-02 | 1.597 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 2.356126e-02 | 1.628 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.387169e-02 | 1.622 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.538050e-02 | 1.595 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.387169e-02 | 1.622 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 2.650619e-02 | 1.577 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 2.763575e-02 | 1.559 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 2.763575e-02 | 1.559 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.763575e-02 | 1.559 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 2.763575e-02 | 1.559 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.837379e-02 | 1.547 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.837379e-02 | 1.547 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.856188e-02 | 1.544 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 2.856188e-02 | 1.544 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 2.869070e-02 | 1.542 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 2.892309e-02 | 1.539 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 2.904279e-02 | 1.537 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 2.904279e-02 | 1.537 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.904279e-02 | 1.537 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 2.904279e-02 | 1.537 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 2.904279e-02 | 1.537 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.918963e-02 | 1.535 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 3.446506e-02 | 1.463 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 3.331352e-02 | 1.477 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 3.391529e-02 | 1.470 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.391529e-02 | 1.470 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 3.391529e-02 | 1.470 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 3.072177e-02 | 1.513 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 3.170164e-02 | 1.499 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 3.170164e-02 | 1.499 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 3.781609e-02 | 1.422 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 3.781609e-02 | 1.422 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 3.114886e-02 | 1.507 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 3.716644e-02 | 1.430 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.630250e-02 | 1.440 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 3.446506e-02 | 1.463 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.529110e-02 | 1.452 | 1 | 0 |
| CaM pathway | R-HSA-111997 | 3.881017e-02 | 1.411 | 1 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.881017e-02 | 1.411 | 1 | 1 |
| Regulation of Apoptosis | R-HSA-169911 | 3.460620e-02 | 1.461 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.529110e-02 | 1.452 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 3.780198e-02 | 1.422 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 3.188640e-02 | 1.496 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.872826e-02 | 1.412 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 3.446506e-02 | 1.463 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 3.755613e-02 | 1.425 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.806519e-02 | 1.419 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 3.659258e-02 | 1.437 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.915010e-02 | 1.407 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 3.391529e-02 | 1.470 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 3.909699e-02 | 1.408 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.274454e-02 | 1.485 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.188640e-02 | 1.496 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.188640e-02 | 1.496 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.774713e-02 | 1.423 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 3.872826e-02 | 1.412 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 3.188640e-02 | 1.496 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 3.072177e-02 | 1.513 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.237851e-02 | 1.490 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 3.391529e-02 | 1.470 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 3.072177e-02 | 1.513 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 3.331352e-02 | 1.477 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.881017e-02 | 1.411 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 3.331352e-02 | 1.477 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 3.391529e-02 | 1.470 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.072177e-02 | 1.513 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.082596e-02 | 1.511 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.806519e-02 | 1.419 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 3.928691e-02 | 1.406 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 3.929026e-02 | 1.406 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 3.930442e-02 | 1.406 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 3.966622e-02 | 1.402 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.977155e-02 | 1.400 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.977155e-02 | 1.400 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 4.026226e-02 | 1.395 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.030477e-02 | 1.395 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 4.126297e-02 | 1.384 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 4.126297e-02 | 1.384 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 4.126297e-02 | 1.384 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 4.126297e-02 | 1.384 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 4.126297e-02 | 1.384 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.126297e-02 | 1.384 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.204144e-02 | 1.376 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 4.224219e-02 | 1.374 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 4.250214e-02 | 1.372 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 4.250214e-02 | 1.372 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 4.250214e-02 | 1.372 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.334234e-02 | 1.363 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 4.334234e-02 | 1.363 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 4.433624e-02 | 1.353 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.433624e-02 | 1.353 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 4.484069e-02 | 1.348 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.484069e-02 | 1.348 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 4.492114e-02 | 1.348 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 4.499802e-02 | 1.347 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.516976e-02 | 1.345 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.516976e-02 | 1.345 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 4.566520e-02 | 1.340 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 4.651908e-02 | 1.332 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.651908e-02 | 1.332 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 4.661060e-02 | 1.332 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 4.670669e-02 | 1.331 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 4.670669e-02 | 1.331 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.690871e-02 | 1.329 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 4.760433e-02 | 1.322 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 4.770489e-02 | 1.321 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 4.770489e-02 | 1.321 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 4.770489e-02 | 1.321 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 4.770489e-02 | 1.321 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.786096e-02 | 1.320 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 4.803417e-02 | 1.318 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 4.879528e-02 | 1.312 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 4.901849e-02 | 1.310 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 4.901849e-02 | 1.310 | 0 | 0 |
| Diseases of cellular response to stress | R-HSA-9675132 | 4.901849e-02 | 1.310 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 4.901849e-02 | 1.310 | 0 | 0 |
| Diseases of Cellular Senescence | R-HSA-9630747 | 4.901849e-02 | 1.310 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.901849e-02 | 1.310 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 4.901849e-02 | 1.310 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 4.901849e-02 | 1.310 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 4.901849e-02 | 1.310 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 4.901849e-02 | 1.310 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 4.901849e-02 | 1.310 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 4.901849e-02 | 1.310 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 4.901849e-02 | 1.310 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 4.901849e-02 | 1.310 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 4.901849e-02 | 1.310 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 7.238136e-02 | 1.140 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 7.238136e-02 | 1.140 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.934264e-02 | 1.227 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.934264e-02 | 1.227 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 7.419702e-02 | 1.130 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.419702e-02 | 1.130 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.419702e-02 | 1.130 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 5.430849e-02 | 1.265 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.430849e-02 | 1.265 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 5.430849e-02 | 1.265 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 5.430849e-02 | 1.265 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.477009e-02 | 1.189 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 5.444210e-02 | 1.264 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.157290e-02 | 1.288 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.850240e-02 | 1.233 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 7.394960e-02 | 1.131 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 5.342038e-02 | 1.272 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 7.324746e-02 | 1.135 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 5.897785e-02 | 1.229 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.241284e-02 | 1.281 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 5.241284e-02 | 1.281 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 5.241284e-02 | 1.281 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 5.741459e-02 | 1.241 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 5.530210e-02 | 1.257 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.196862e-02 | 1.284 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 5.358714e-02 | 1.271 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 7.597023e-02 | 1.119 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.444210e-02 | 1.264 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 7.419702e-02 | 1.130 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.897785e-02 | 1.229 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 7.114950e-02 | 1.148 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.336757e-02 | 1.134 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 5.444210e-02 | 1.264 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.477009e-02 | 1.189 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.196021e-02 | 1.143 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.196021e-02 | 1.143 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 6.511121e-02 | 1.186 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.324746e-02 | 1.135 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 6.488665e-02 | 1.188 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 7.114950e-02 | 1.148 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 7.199907e-02 | 1.143 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 5.127341e-02 | 1.290 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 5.934264e-02 | 1.227 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 5.837050e-02 | 1.234 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.488665e-02 | 1.188 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.288962e-02 | 1.277 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.288962e-02 | 1.277 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 5.957864e-02 | 1.225 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 7.199907e-02 | 1.143 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 6.488665e-02 | 1.188 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 6.708996e-02 | 1.173 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 7.578630e-02 | 1.120 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 5.338129e-02 | 1.273 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 5.315237e-02 | 1.274 | 1 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 7.238136e-02 | 1.140 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 5.897785e-02 | 1.229 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 6.488665e-02 | 1.188 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 6.271417e-02 | 1.203 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.287412e-02 | 1.202 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.596128e-02 | 1.181 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 7.199907e-02 | 1.143 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.975645e-02 | 1.224 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 6.007666e-02 | 1.221 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 5.957864e-02 | 1.225 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 6.620009e-02 | 1.179 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 7.324746e-02 | 1.135 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.476456e-02 | 1.126 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 7.057445e-02 | 1.151 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 5.270240e-02 | 1.278 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 5.430849e-02 | 1.265 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 5.430849e-02 | 1.265 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 6.269360e-02 | 1.203 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 5.157290e-02 | 1.288 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 5.157290e-02 | 1.288 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 6.477009e-02 | 1.189 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 6.425015e-02 | 1.192 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 5.430849e-02 | 1.265 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 5.430849e-02 | 1.265 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 6.722279e-02 | 1.172 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 7.394960e-02 | 1.131 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 7.568779e-02 | 1.121 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.711353e-02 | 1.173 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 7.199907e-02 | 1.143 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.620293e-02 | 1.118 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 7.620293e-02 | 1.118 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 7.911457e-02 | 1.102 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 8.072074e-02 | 1.093 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 8.072074e-02 | 1.093 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 8.072074e-02 | 1.093 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 8.139843e-02 | 1.089 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 8.139843e-02 | 1.089 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 8.179802e-02 | 1.087 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.180826e-02 | 1.087 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.180826e-02 | 1.087 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.246447e-02 | 1.084 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.246447e-02 | 1.084 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 8.246447e-02 | 1.084 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 8.246447e-02 | 1.084 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p14ARF Defects | R-HSA-9646304 | 8.412424e-02 | 1.075 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p14ARF Defects | R-HSA-9646303 | 8.412424e-02 | 1.075 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.412424e-02 | 1.075 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 8.515594e-02 | 1.070 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.635154e-02 | 1.064 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.635154e-02 | 1.064 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 8.797405e-02 | 1.056 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 8.829836e-02 | 1.054 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.857523e-02 | 1.053 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.857523e-02 | 1.053 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 8.857523e-02 | 1.053 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.857523e-02 | 1.053 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.857523e-02 | 1.053 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.857523e-02 | 1.053 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 8.857523e-02 | 1.053 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 8.861806e-02 | 1.052 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 8.861806e-02 | 1.052 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 8.861806e-02 | 1.052 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 8.861806e-02 | 1.052 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 9.010452e-02 | 1.045 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 9.051860e-02 | 1.043 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 9.051860e-02 | 1.043 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 9.051860e-02 | 1.043 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 9.051860e-02 | 1.043 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 9.051860e-02 | 1.043 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 9.051860e-02 | 1.043 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 9.150022e-02 | 1.039 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.150022e-02 | 1.039 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.207061e-02 | 1.036 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.228826e-02 | 1.035 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.310480e-02 | 1.031 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 9.375778e-02 | 1.028 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.392572e-02 | 1.027 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.392572e-02 | 1.027 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 9.564277e-02 | 1.019 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.693575e-02 | 1.014 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.693575e-02 | 1.014 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 9.693575e-02 | 1.014 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 9.854420e-02 | 1.006 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 9.854420e-02 | 1.006 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 9.854420e-02 | 1.006 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.975164e-02 | 1.001 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 9.975164e-02 | 1.001 | 1 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.975164e-02 | 1.001 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.975164e-02 | 1.001 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 1.001139e-01 | 1.000 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 1.005316e-01 | 0.998 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 1.008787e-01 | 0.996 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 1.008801e-01 | 0.996 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.010485e-01 | 0.995 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 1.018472e-01 | 0.992 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.018472e-01 | 0.992 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 1.027881e-01 | 0.988 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 1.034213e-01 | 0.985 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.034213e-01 | 0.985 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 1.034213e-01 | 0.985 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.065377e-01 | 0.972 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 1.077712e-01 | 0.967 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 1.077815e-01 | 0.967 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.081822e-01 | 0.966 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.081822e-01 | 0.966 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 1.081822e-01 | 0.966 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.110983e-01 | 0.954 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 1.110983e-01 | 0.954 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.146394e-01 | 0.941 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 1.148090e-01 | 0.940 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 1.148090e-01 | 0.940 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 1.148090e-01 | 0.940 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 1.148090e-01 | 0.940 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.159721e-01 | 0.936 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 1.159721e-01 | 0.936 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 1.160199e-01 | 0.935 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.160199e-01 | 0.935 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 1.160427e-01 | 0.935 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 1.161554e-01 | 0.935 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.195736e-01 | 0.922 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.201827e-01 | 0.920 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 1.201827e-01 | 0.920 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.208517e-01 | 0.918 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.240330e-01 | 0.906 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 1.243487e-01 | 0.905 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 1.243487e-01 | 0.905 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 1.250487e-01 | 0.903 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.268713e-01 | 0.897 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 1.270542e-01 | 0.896 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.275556e-01 | 0.894 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 1.298969e-01 | 0.886 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.611762e-01 | 0.793 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 1.611762e-01 | 0.793 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.611762e-01 | 0.793 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.611762e-01 | 0.793 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.611762e-01 | 0.793 | 0 | 0 |
| Hereditary fructose intolerance | R-HSA-5657560 | 1.611762e-01 | 0.793 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9632697 | 1.611762e-01 | 0.793 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.611762e-01 | 0.793 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.611762e-01 | 0.793 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.611762e-01 | 0.793 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.611762e-01 | 0.793 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.611762e-01 | 0.793 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 | R-HSA-9630791 | 1.611762e-01 | 0.793 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to p16INK4A Defects | R-HSA-9630750 | 2.317500e-01 | 0.635 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to p16INK4A Defects | R-HSA-9632693 | 2.317500e-01 | 0.635 | 0 | 0 |
| Defective SLC26A2 causes chondrodysplasias | R-HSA-3560792 | 2.317500e-01 | 0.635 | 0 | 0 |
| Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA) | R-HSA-5619050 | 2.317500e-01 | 0.635 | 0 | 0 |
| Evasion of Oncogene Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9630794 | 2.317500e-01 | 0.635 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.317500e-01 | 0.635 | 0 | 0 |
| Evasion of Oxidative Stress Induced Senescence Due to Defective p16INK4A binding to CDK4 and CDK6 | R-HSA-9632700 | 2.317500e-01 | 0.635 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.568139e-01 | 0.805 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.568139e-01 | 0.805 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.568139e-01 | 0.805 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 1.879003e-01 | 0.726 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 1.879003e-01 | 0.726 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 1.469967e-01 | 0.833 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.197266e-01 | 0.658 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 2.197266e-01 | 0.658 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.678702e-01 | 0.775 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 1.308978e-01 | 0.883 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.308978e-01 | 0.883 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 1.465675e-01 | 0.834 | 0 | 0 |
| PKA activation | R-HSA-163615 | 1.465675e-01 | 0.834 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 1.629209e-01 | 0.788 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 2.118612e-01 | 0.674 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 1.680025e-01 | 0.775 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 1.680025e-01 | 0.775 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 1.441126e-01 | 0.841 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.579699e-01 | 0.588 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.579699e-01 | 0.588 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.824853e-01 | 0.739 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.824853e-01 | 0.739 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.560139e-01 | 0.807 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.338961e-01 | 0.631 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 2.527051e-01 | 0.597 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 2.527051e-01 | 0.597 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.323349e-01 | 0.878 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.629439e-01 | 0.788 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.212677e-01 | 0.655 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.460963e-01 | 0.835 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 2.012801e-01 | 0.696 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.352946e-01 | 0.628 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.406175e-01 | 0.852 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.762086e-01 | 0.754 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 1.695167e-01 | 0.771 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 2.517267e-01 | 0.599 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 2.504000e-01 | 0.601 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.284178e-01 | 0.641 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 1.469967e-01 | 0.833 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 1.974260e-01 | 0.705 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 1.469967e-01 | 0.833 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.895367e-01 | 0.722 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 1.445836e-01 | 0.840 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 1.974078e-01 | 0.705 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 1.465675e-01 | 0.834 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 2.579699e-01 | 0.588 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.432777e-01 | 0.844 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 2.284178e-01 | 0.641 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 2.607177e-01 | 0.584 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.475753e-01 | 0.831 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 2.387495e-01 | 0.622 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 1.776305e-01 | 0.750 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 1.776305e-01 | 0.750 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.484053e-01 | 0.605 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 1.529587e-01 | 0.815 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.589132e-01 | 0.799 | 1 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.352946e-01 | 0.628 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.352946e-01 | 0.628 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.683063e-01 | 0.774 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.678702e-01 | 0.775 | 0 | 0 |
| Translation | R-HSA-72766 | 2.092184e-01 | 0.679 | 0 | 0 |
| Activation and oligomerization of BAK protein | R-HSA-111452 | 1.611762e-01 | 0.793 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 1.469967e-01 | 0.833 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 1.308978e-01 | 0.883 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 2.519484e-01 | 0.599 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 2.519484e-01 | 0.599 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 1.405031e-01 | 0.852 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.607177e-01 | 0.584 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 1.603554e-01 | 0.795 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 1.441126e-01 | 0.841 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 1.678702e-01 | 0.775 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.851021e-01 | 0.733 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 1.970776e-01 | 0.705 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 2.403569e-01 | 0.619 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.188768e-01 | 0.660 | 1 | 0 |
| Interleukin-23 signaling | R-HSA-9020933 | 2.519484e-01 | 0.599 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 1.547131e-01 | 0.810 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 1.879003e-01 | 0.726 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 1.445836e-01 | 0.840 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 2.360207e-01 | 0.627 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 2.338961e-01 | 0.631 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 1.678702e-01 | 0.775 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.524506e-01 | 0.598 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 1.405031e-01 | 0.852 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 1.537271e-01 | 0.813 | 1 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 1.326469e-01 | 0.877 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.736546e-01 | 0.760 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.611762e-01 | 0.793 | 0 | 0 |
| Activation, translocation and oligomerization of BAX | R-HSA-114294 | 1.611762e-01 | 0.793 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.317500e-01 | 0.635 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 2.317500e-01 | 0.635 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 1.308978e-01 | 0.883 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 2.347137e-01 | 0.629 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.347137e-01 | 0.629 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.579699e-01 | 0.588 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 1.974078e-01 | 0.705 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 1.425496e-01 | 0.846 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 1.539966e-01 | 0.812 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 1.629439e-01 | 0.788 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 2.519484e-01 | 0.599 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 1.342775e-01 | 0.872 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 2.347137e-01 | 0.629 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 2.347137e-01 | 0.629 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 2.607177e-01 | 0.584 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 1.927375e-01 | 0.715 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 1.927375e-01 | 0.715 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.560912e-01 | 0.807 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.118612e-01 | 0.674 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 2.579699e-01 | 0.588 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.352946e-01 | 0.628 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 1.560139e-01 | 0.807 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.212677e-01 | 0.655 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 1.776305e-01 | 0.750 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.562910e-01 | 0.806 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 1.538981e-01 | 0.813 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.352946e-01 | 0.628 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 1.631540e-01 | 0.787 | 1 | 0 |
| Reproduction | R-HSA-1474165 | 1.514812e-01 | 0.820 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 1.879003e-01 | 0.726 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 1.629209e-01 | 0.788 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 1.326469e-01 | 0.877 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.560139e-01 | 0.807 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 2.212677e-01 | 0.655 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.212677e-01 | 0.655 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 2.607177e-01 | 0.584 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.720309e-01 | 0.764 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 1.895367e-01 | 0.722 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 1.545070e-01 | 0.811 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 2.348713e-01 | 0.629 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 2.056994e-01 | 0.687 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.939184e-01 | 0.712 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.326469e-01 | 0.877 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.338961e-01 | 0.631 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.773442e-01 | 0.751 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 1.465675e-01 | 0.834 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.558610e-01 | 0.592 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.558610e-01 | 0.592 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.558610e-01 | 0.592 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.197266e-01 | 0.658 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.680025e-01 | 0.775 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 2.154481e-01 | 0.667 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 2.284178e-01 | 0.641 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.387495e-01 | 0.622 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 2.075317e-01 | 0.683 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 1.973346e-01 | 0.705 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 2.338961e-01 | 0.631 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.629209e-01 | 0.788 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 2.338961e-01 | 0.631 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.197266e-01 | 0.658 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 2.527051e-01 | 0.597 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.342775e-01 | 0.872 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.974260e-01 | 0.705 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.662749e-01 | 0.779 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.519484e-01 | 0.599 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 2.127317e-01 | 0.672 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 1.631540e-01 | 0.787 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 2.056994e-01 | 0.687 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.609834e-01 | 0.583 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 2.641124e-01 | 0.578 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 2.641124e-01 | 0.578 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 2.644799e-01 | 0.578 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.676195e-01 | 0.572 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 2.717094e-01 | 0.566 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.768007e-01 | 0.558 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 2.788484e-01 | 0.555 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 2.815126e-01 | 0.551 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 2.815126e-01 | 0.551 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 2.815126e-01 | 0.551 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 2.815126e-01 | 0.551 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 2.815126e-01 | 0.551 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.842743e-01 | 0.546 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.842743e-01 | 0.546 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 2.842743e-01 | 0.546 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.842743e-01 | 0.546 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.842743e-01 | 0.546 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.842743e-01 | 0.546 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.842743e-01 | 0.546 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 2.842743e-01 | 0.546 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.842743e-01 | 0.546 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.842743e-01 | 0.546 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 2.891687e-01 | 0.539 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 2.911529e-01 | 0.536 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 2.911529e-01 | 0.536 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.911529e-01 | 0.536 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.925564e-01 | 0.534 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 2.939895e-01 | 0.532 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 2.963899e-01 | 0.528 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 2.963899e-01 | 0.528 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 2.963899e-01 | 0.528 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.963899e-01 | 0.528 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.963899e-01 | 0.528 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 2.963899e-01 | 0.528 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 2.963899e-01 | 0.528 | 0 | 0 |
| ATF6B (ATF6-beta) activates chaperones | R-HSA-8874177 | 2.963899e-01 | 0.528 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.977941e-01 | 0.526 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.052319e-01 | 0.515 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.052319e-01 | 0.515 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 3.052319e-01 | 0.515 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 3.087006e-01 | 0.510 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 3.106691e-01 | 0.508 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 3.106691e-01 | 0.508 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 3.106691e-01 | 0.508 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.106691e-01 | 0.508 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 3.106691e-01 | 0.508 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.108916e-01 | 0.507 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 3.146100e-01 | 0.502 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 3.164590e-01 | 0.500 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.164590e-01 | 0.500 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 3.164590e-01 | 0.500 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.164590e-01 | 0.500 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 3.164590e-01 | 0.500 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 3.164590e-01 | 0.500 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 3.164590e-01 | 0.500 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 3.164590e-01 | 0.500 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.164590e-01 | 0.500 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.164590e-01 | 0.500 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.271123e-01 | 0.485 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 3.279203e-01 | 0.484 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 3.285316e-01 | 0.483 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 3.290256e-01 | 0.483 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.290256e-01 | 0.483 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.290256e-01 | 0.483 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 3.303021e-01 | 0.481 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 3.333955e-01 | 0.477 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 3.336015e-01 | 0.477 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 3.339503e-01 | 0.476 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 3.383408e-01 | 0.471 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.383408e-01 | 0.471 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.393333e-01 | 0.469 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 3.448968e-01 | 0.462 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.450383e-01 | 0.462 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 3.457077e-01 | 0.461 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 3.482974e-01 | 0.458 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 3.482974e-01 | 0.458 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 3.482974e-01 | 0.458 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 3.482974e-01 | 0.458 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 3.482974e-01 | 0.458 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 3.499964e-01 | 0.456 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 3.499964e-01 | 0.456 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 3.527996e-01 | 0.452 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 3.527996e-01 | 0.452 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 3.527996e-01 | 0.452 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.527996e-01 | 0.452 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 3.527996e-01 | 0.452 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 3.527996e-01 | 0.452 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.533442e-01 | 0.452 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 3.533535e-01 | 0.452 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 3.533535e-01 | 0.452 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.533535e-01 | 0.452 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.547051e-01 | 0.450 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 3.555947e-01 | 0.449 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 3.555947e-01 | 0.449 | 0 | 0 |
| 3-Methylcrotonyl-CoA carboxylase deficiency | R-HSA-9909438 | 3.555947e-01 | 0.449 | 0 | 0 |
| Signalling to STAT3 | R-HSA-198745 | 3.555947e-01 | 0.449 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 3.555947e-01 | 0.449 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 3.555947e-01 | 0.449 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.555947e-01 | 0.449 | 0 | 0 |
| CASP5-mediated substrate cleavage | R-HSA-9960525 | 3.555947e-01 | 0.449 | 0 | 0 |
| CASP4-mediated substrate cleavage | R-HSA-9960519 | 3.555947e-01 | 0.449 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 3.559387e-01 | 0.449 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.622097e-01 | 0.441 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 3.622097e-01 | 0.441 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 3.622097e-01 | 0.441 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 3.663424e-01 | 0.436 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.663424e-01 | 0.436 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 3.694961e-01 | 0.432 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.696994e-01 | 0.432 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 3.696994e-01 | 0.432 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 3.696994e-01 | 0.432 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 3.696994e-01 | 0.432 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.696994e-01 | 0.432 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.696994e-01 | 0.432 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.701248e-01 | 0.432 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 3.725050e-01 | 0.429 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 3.729195e-01 | 0.428 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 3.764679e-01 | 0.424 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 3.764679e-01 | 0.424 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 3.764679e-01 | 0.424 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 3.764679e-01 | 0.424 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 3.764679e-01 | 0.424 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.767865e-01 | 0.424 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.793998e-01 | 0.421 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.796203e-01 | 0.421 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 3.796203e-01 | 0.421 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.796203e-01 | 0.421 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 3.796203e-01 | 0.421 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.796203e-01 | 0.421 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 3.796203e-01 | 0.421 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.808695e-01 | 0.419 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 3.860793e-01 | 0.413 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 3.881327e-01 | 0.411 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 3.881327e-01 | 0.411 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.893613e-01 | 0.410 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.893613e-01 | 0.410 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 3.897187e-01 | 0.409 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.965754e-01 | 0.402 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 3.965754e-01 | 0.402 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 3.965754e-01 | 0.402 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.965754e-01 | 0.402 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 3.970870e-01 | 0.401 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.970870e-01 | 0.401 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.038620e-01 | 0.394 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 4.089354e-01 | 0.388 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.098209e-01 | 0.387 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.098209e-01 | 0.387 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 4.098209e-01 | 0.387 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.098209e-01 | 0.387 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.098209e-01 | 0.387 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 4.102889e-01 | 0.387 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.102889e-01 | 0.387 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 4.102889e-01 | 0.387 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 4.102889e-01 | 0.387 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.102889e-01 | 0.387 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 4.102889e-01 | 0.387 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 4.137045e-01 | 0.383 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 4.179932e-01 | 0.379 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.183568e-01 | 0.378 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.183568e-01 | 0.378 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 4.188125e-01 | 0.378 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.191429e-01 | 0.378 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.283781e-01 | 0.368 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 4.284491e-01 | 0.368 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.301736e-01 | 0.366 | 1 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 4.307321e-01 | 0.366 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 4.307571e-01 | 0.366 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 4.315272e-01 | 0.365 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 4.401919e-01 | 0.356 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 4.401919e-01 | 0.356 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 4.401919e-01 | 0.356 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 4.436436e-01 | 0.353 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 4.450224e-01 | 0.352 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 4.460958e-01 | 0.351 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.476491e-01 | 0.349 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.476491e-01 | 0.349 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.476491e-01 | 0.349 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 4.476491e-01 | 0.349 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.592516e-01 | 0.338 | 0 | 0 |
| IRS activation | R-HSA-74713 | 4.594870e-01 | 0.338 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.594870e-01 | 0.338 | 0 | 0 |
| Defective SLC1A3 causes episodic ataxia 6 (EA6) | R-HSA-5619062 | 4.594870e-01 | 0.338 | 0 | 0 |
| PTK6 Activates STAT3 | R-HSA-8849474 | 4.594870e-01 | 0.338 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.594870e-01 | 0.338 | 0 | 0 |
| Toxicity of botulinum toxin type G (botG) | R-HSA-5250989 | 4.594870e-01 | 0.338 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 4.594870e-01 | 0.338 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 4.594870e-01 | 0.338 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 4.594870e-01 | 0.338 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 4.594870e-01 | 0.338 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.594870e-01 | 0.338 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.594870e-01 | 0.338 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 4.594870e-01 | 0.338 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.645196e-01 | 0.333 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.645196e-01 | 0.333 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 4.667111e-01 | 0.331 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 4.686366e-01 | 0.329 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 4.686366e-01 | 0.329 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 4.686366e-01 | 0.329 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.692408e-01 | 0.329 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 4.692408e-01 | 0.329 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 4.692408e-01 | 0.329 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 4.839088e-01 | 0.315 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 4.855301e-01 | 0.314 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.855301e-01 | 0.314 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 4.855301e-01 | 0.314 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 4.855301e-01 | 0.314 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.855301e-01 | 0.314 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 4.855301e-01 | 0.314 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 4.855425e-01 | 0.314 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 4.878740e-01 | 0.312 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 4.907562e-01 | 0.309 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.907562e-01 | 0.309 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 4.907562e-01 | 0.309 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.907562e-01 | 0.309 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 4.907562e-01 | 0.309 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 4.918191e-01 | 0.308 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.967214e-01 | 0.304 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 4.973677e-01 | 0.303 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 4.973677e-01 | 0.303 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 4.973677e-01 | 0.303 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 4.973677e-01 | 0.303 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.976544e-01 | 0.303 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 4.999316e-01 | 0.301 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 5.015856e-01 | 0.300 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 5.025083e-01 | 0.299 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 5.040751e-01 | 0.298 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.049761e-01 | 0.297 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.049761e-01 | 0.297 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.049761e-01 | 0.297 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.049761e-01 | 0.297 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.049761e-01 | 0.297 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 5.049761e-01 | 0.297 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 5.049761e-01 | 0.297 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 5.049761e-01 | 0.297 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.049761e-01 | 0.297 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.049761e-01 | 0.297 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.049761e-01 | 0.297 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.049761e-01 | 0.297 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 5.049761e-01 | 0.297 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.049761e-01 | 0.297 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 5.049761e-01 | 0.297 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 5.094396e-01 | 0.293 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 5.102507e-01 | 0.292 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 5.124125e-01 | 0.290 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 5.139288e-01 | 0.289 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 5.139288e-01 | 0.289 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.212378e-01 | 0.283 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.223181e-01 | 0.282 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.245222e-01 | 0.280 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 5.245222e-01 | 0.280 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 5.245222e-01 | 0.280 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.245222e-01 | 0.280 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 5.245222e-01 | 0.280 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.286312e-01 | 0.277 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.299805e-01 | 0.276 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 5.335696e-01 | 0.273 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.353185e-01 | 0.271 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 5.363734e-01 | 0.271 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.363734e-01 | 0.271 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 5.398576e-01 | 0.268 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 5.398576e-01 | 0.268 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 5.457912e-01 | 0.263 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.457912e-01 | 0.263 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 5.457912e-01 | 0.263 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.466394e-01 | 0.262 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.466394e-01 | 0.262 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 5.466394e-01 | 0.262 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 5.466394e-01 | 0.262 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 5.466394e-01 | 0.262 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 5.466394e-01 | 0.262 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 5.466394e-01 | 0.262 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 5.466394e-01 | 0.262 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.466394e-01 | 0.262 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 5.466394e-01 | 0.262 | 0 | 0 |
| VLDL assembly | R-HSA-8866423 | 5.466394e-01 | 0.262 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 5.466394e-01 | 0.262 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 5.469220e-01 | 0.262 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 5.475011e-01 | 0.262 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 5.506686e-01 | 0.259 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 5.506686e-01 | 0.259 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.506686e-01 | 0.259 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 5.541972e-01 | 0.256 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.541972e-01 | 0.256 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 5.541972e-01 | 0.256 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 5.541972e-01 | 0.256 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 5.550923e-01 | 0.256 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 5.578014e-01 | 0.254 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 5.578014e-01 | 0.254 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.685932e-01 | 0.245 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.742703e-01 | 0.241 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.750002e-01 | 0.240 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 5.757844e-01 | 0.240 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.757844e-01 | 0.240 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.757844e-01 | 0.240 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 5.757844e-01 | 0.240 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 5.757844e-01 | 0.240 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 5.847984e-01 | 0.233 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 5.847984e-01 | 0.233 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 5.847984e-01 | 0.233 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 5.847984e-01 | 0.233 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 5.847984e-01 | 0.233 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.847984e-01 | 0.233 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 5.847984e-01 | 0.233 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.847984e-01 | 0.233 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 5.847984e-01 | 0.233 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 5.847984e-01 | 0.233 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.847984e-01 | 0.233 | 0 | 0 |
| LDL remodeling | R-HSA-8964041 | 5.847984e-01 | 0.233 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.847984e-01 | 0.233 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.847984e-01 | 0.233 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 5.847984e-01 | 0.233 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.847984e-01 | 0.233 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 5.916186e-01 | 0.228 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.918137e-01 | 0.228 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.918137e-01 | 0.228 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.918137e-01 | 0.228 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 5.918137e-01 | 0.228 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.998577e-01 | 0.222 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 5.998577e-01 | 0.222 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.998577e-01 | 0.222 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 5.998577e-01 | 0.222 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.002319e-01 | 0.222 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.014329e-01 | 0.221 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.021019e-01 | 0.220 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 6.057318e-01 | 0.218 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 6.063146e-01 | 0.217 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.101207e-01 | 0.215 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 6.126778e-01 | 0.213 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 6.126778e-01 | 0.213 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 6.126778e-01 | 0.213 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 6.126778e-01 | 0.213 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.126778e-01 | 0.213 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 6.197477e-01 | 0.208 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.197477e-01 | 0.208 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.197477e-01 | 0.208 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 6.197477e-01 | 0.208 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 6.197477e-01 | 0.208 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 6.197477e-01 | 0.208 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.197477e-01 | 0.208 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 6.197477e-01 | 0.208 | 0 | 0 |
| Toxicity of botulinum toxin type B (botB) | R-HSA-5250958 | 6.197477e-01 | 0.208 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 6.197477e-01 | 0.208 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.197477e-01 | 0.208 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 6.197477e-01 | 0.208 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.197477e-01 | 0.208 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.197477e-01 | 0.208 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.197477e-01 | 0.208 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.228862e-01 | 0.206 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.228862e-01 | 0.206 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 6.228862e-01 | 0.206 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 6.239633e-01 | 0.205 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.242307e-01 | 0.205 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.242307e-01 | 0.205 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.242307e-01 | 0.205 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 6.309854e-01 | 0.200 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 6.309854e-01 | 0.200 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.309854e-01 | 0.200 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 6.363230e-01 | 0.196 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.398125e-01 | 0.194 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.398125e-01 | 0.194 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 6.398125e-01 | 0.194 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 6.398125e-01 | 0.194 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 6.403029e-01 | 0.194 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 6.448751e-01 | 0.191 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.448751e-01 | 0.191 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 6.448751e-01 | 0.191 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.448751e-01 | 0.191 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 6.448751e-01 | 0.191 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 6.486840e-01 | 0.188 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.486840e-01 | 0.188 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 6.517571e-01 | 0.186 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 6.517571e-01 | 0.186 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.517571e-01 | 0.186 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 6.517571e-01 | 0.186 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.517571e-01 | 0.186 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 6.517571e-01 | 0.186 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.517571e-01 | 0.186 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 6.517571e-01 | 0.186 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.517571e-01 | 0.186 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 6.517571e-01 | 0.186 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 6.517571e-01 | 0.186 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 6.517571e-01 | 0.186 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 6.517571e-01 | 0.186 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.535223e-01 | 0.185 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.549658e-01 | 0.184 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 6.585899e-01 | 0.181 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 6.619302e-01 | 0.179 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 6.648696e-01 | 0.177 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 6.652937e-01 | 0.177 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 6.657696e-01 | 0.177 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 6.657696e-01 | 0.177 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.658363e-01 | 0.177 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.658363e-01 | 0.177 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.658363e-01 | 0.177 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 6.696849e-01 | 0.174 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 6.810527e-01 | 0.167 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 6.810736e-01 | 0.167 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.810736e-01 | 0.167 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 6.810736e-01 | 0.167 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 6.810736e-01 | 0.167 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 6.810736e-01 | 0.167 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 6.810736e-01 | 0.167 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.810736e-01 | 0.167 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 6.822411e-01 | 0.166 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.822411e-01 | 0.166 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.822411e-01 | 0.166 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.839660e-01 | 0.165 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.839660e-01 | 0.165 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 6.839660e-01 | 0.165 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.857869e-01 | 0.164 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.978069e-01 | 0.156 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 7.001371e-01 | 0.155 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 7.047484e-01 | 0.152 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.047484e-01 | 0.152 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 7.047484e-01 | 0.152 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.079238e-01 | 0.150 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 7.079238e-01 | 0.150 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 7.079238e-01 | 0.150 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 7.079238e-01 | 0.150 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 7.079238e-01 | 0.150 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 7.079238e-01 | 0.150 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 7.079238e-01 | 0.150 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.079238e-01 | 0.150 | 0 | 0 |
| Inorganic anion exchange by SLC26 transporters | R-HSA-427601 | 7.079238e-01 | 0.150 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 7.079238e-01 | 0.150 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.079238e-01 | 0.150 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 7.079238e-01 | 0.150 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.079238e-01 | 0.150 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 7.131300e-01 | 0.147 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 7.133507e-01 | 0.147 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 7.147194e-01 | 0.146 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.171292e-01 | 0.144 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.227461e-01 | 0.141 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 7.227461e-01 | 0.141 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 7.227461e-01 | 0.141 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.238885e-01 | 0.140 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 7.241677e-01 | 0.140 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 7.241677e-01 | 0.140 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 7.279990e-01 | 0.138 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 7.279990e-01 | 0.138 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 7.325150e-01 | 0.135 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 7.325150e-01 | 0.135 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 7.325150e-01 | 0.135 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 7.325150e-01 | 0.135 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 7.325150e-01 | 0.135 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 7.325150e-01 | 0.135 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 7.325150e-01 | 0.135 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.325150e-01 | 0.135 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 7.352460e-01 | 0.134 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 7.358742e-01 | 0.133 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 7.366905e-01 | 0.133 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 7.376945e-01 | 0.132 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.398077e-01 | 0.131 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.398077e-01 | 0.131 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 7.398077e-01 | 0.131 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 7.420533e-01 | 0.130 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.420533e-01 | 0.130 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 7.420533e-01 | 0.130 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 7.550370e-01 | 0.122 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.550370e-01 | 0.122 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.550370e-01 | 0.122 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.550370e-01 | 0.122 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.550370e-01 | 0.122 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.550370e-01 | 0.122 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 7.550370e-01 | 0.122 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 7.550370e-01 | 0.122 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.550370e-01 | 0.122 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.550370e-01 | 0.122 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.550370e-01 | 0.122 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 7.550370e-01 | 0.122 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.550370e-01 | 0.122 | 0 | 0 |
| Erythrocytes take up oxygen and release carbon dioxide | R-HSA-1247673 | 7.550370e-01 | 0.122 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.550370e-01 | 0.122 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.555233e-01 | 0.122 | 0 | 0 |
| Depurination | R-HSA-73927 | 7.555233e-01 | 0.122 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 7.559633e-01 | 0.121 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.559633e-01 | 0.121 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.559633e-01 | 0.121 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 7.559633e-01 | 0.121 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 7.559633e-01 | 0.121 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 7.684202e-01 | 0.114 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 7.712444e-01 | 0.113 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 7.716717e-01 | 0.113 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 7.739882e-01 | 0.111 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 7.756639e-01 | 0.110 | 0 | 0 |
| Microbial factors inhibit CASP4 activity | R-HSA-9956593 | 7.756639e-01 | 0.110 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 7.756639e-01 | 0.110 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 7.756639e-01 | 0.110 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 7.756639e-01 | 0.110 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 7.756639e-01 | 0.110 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 7.756639e-01 | 0.110 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 7.756639e-01 | 0.110 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 7.756639e-01 | 0.110 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 7.756639e-01 | 0.110 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.807563e-01 | 0.107 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 7.823229e-01 | 0.107 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 7.856837e-01 | 0.105 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.856837e-01 | 0.105 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 7.876976e-01 | 0.104 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 7.925451e-01 | 0.101 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.925451e-01 | 0.101 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 7.928919e-01 | 0.101 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 7.941151e-01 | 0.100 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.945551e-01 | 0.100 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.945551e-01 | 0.100 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 7.945551e-01 | 0.100 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.945551e-01 | 0.100 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 7.945551e-01 | 0.100 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 7.945551e-01 | 0.100 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.945551e-01 | 0.100 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 7.945551e-01 | 0.100 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.945551e-01 | 0.100 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.945551e-01 | 0.100 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 7.945551e-01 | 0.100 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 7.975286e-01 | 0.098 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 7.976545e-01 | 0.098 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 7.976545e-01 | 0.098 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 7.976545e-01 | 0.098 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 7.993145e-01 | 0.097 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.993145e-01 | 0.097 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 7.993145e-01 | 0.097 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 8.064436e-01 | 0.093 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 8.072500e-01 | 0.093 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 8.092065e-01 | 0.092 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 8.097283e-01 | 0.092 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.113676e-01 | 0.091 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 8.113676e-01 | 0.091 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 8.118565e-01 | 0.091 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 8.118565e-01 | 0.091 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 8.118565e-01 | 0.091 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 8.118565e-01 | 0.091 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.118565e-01 | 0.091 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 8.118565e-01 | 0.091 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.118565e-01 | 0.091 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.118565e-01 | 0.091 | 0 | 0 |
| Transport and metabolism of PAPS | R-HSA-174362 | 8.118565e-01 | 0.091 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.121707e-01 | 0.090 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.121707e-01 | 0.090 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.121707e-01 | 0.090 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 8.125258e-01 | 0.090 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 8.145384e-01 | 0.089 | 0 | 0 |
| Immune System | R-HSA-168256 | 8.175962e-01 | 0.087 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.177955e-01 | 0.087 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 8.182807e-01 | 0.087 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 8.223155e-01 | 0.085 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.242860e-01 | 0.084 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 8.247732e-01 | 0.084 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.247732e-01 | 0.084 | 0 | 0 |
| Entry of Influenza Virion into Host Cell via Endocytosis | R-HSA-168275 | 8.277018e-01 | 0.082 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 8.277018e-01 | 0.082 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.277018e-01 | 0.082 | 1 | 1 |
| Fructose catabolism | R-HSA-70350 | 8.277018e-01 | 0.082 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 8.277018e-01 | 0.082 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 8.277018e-01 | 0.082 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 8.277018e-01 | 0.082 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.277018e-01 | 0.082 | 0 | 0 |
| Attachment and Entry | R-HSA-9678110 | 8.277018e-01 | 0.082 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.277018e-01 | 0.082 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.277018e-01 | 0.082 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.298618e-01 | 0.081 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.298618e-01 | 0.081 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 8.303838e-01 | 0.081 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 8.322237e-01 | 0.080 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 8.345211e-01 | 0.079 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.356939e-01 | 0.078 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 8.356939e-01 | 0.078 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 8.407148e-01 | 0.075 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 8.418297e-01 | 0.075 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 8.421327e-01 | 0.075 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.422135e-01 | 0.075 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 8.422135e-01 | 0.075 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.422135e-01 | 0.075 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.422135e-01 | 0.075 | 0 | 0 |
| Fibronectin matrix formation | R-HSA-1566977 | 8.422135e-01 | 0.075 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.422135e-01 | 0.075 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 8.422135e-01 | 0.075 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 8.422135e-01 | 0.075 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.422135e-01 | 0.075 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.422135e-01 | 0.075 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 8.437982e-01 | 0.074 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.437982e-01 | 0.074 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.437982e-01 | 0.074 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.464276e-01 | 0.072 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 8.471452e-01 | 0.072 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.526207e-01 | 0.069 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.526207e-01 | 0.069 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.549115e-01 | 0.068 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.555038e-01 | 0.068 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 8.555038e-01 | 0.068 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.555038e-01 | 0.068 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.565197e-01 | 0.067 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.565197e-01 | 0.067 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 8.565197e-01 | 0.067 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 8.623397e-01 | 0.064 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.660022e-01 | 0.062 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.660022e-01 | 0.062 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 8.676753e-01 | 0.062 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.676753e-01 | 0.062 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 8.676753e-01 | 0.062 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 8.727131e-01 | 0.059 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 8.727131e-01 | 0.059 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.740510e-01 | 0.058 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 8.749061e-01 | 0.058 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.749061e-01 | 0.058 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 8.749061e-01 | 0.058 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 8.749061e-01 | 0.058 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 8.788223e-01 | 0.056 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 8.788223e-01 | 0.056 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 8.788223e-01 | 0.056 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 8.788223e-01 | 0.056 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 8.788223e-01 | 0.056 | 0 | 0 |
| O2/CO2 exchange in erythrocytes | R-HSA-1480926 | 8.788223e-01 | 0.056 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.788223e-01 | 0.056 | 0 | 0 |
| Erythrocytes take up carbon dioxide and release oxygen | R-HSA-1237044 | 8.788223e-01 | 0.056 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.832615e-01 | 0.054 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 8.832615e-01 | 0.054 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 8.832615e-01 | 0.054 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.836925e-01 | 0.054 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 8.890308e-01 | 0.051 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.890308e-01 | 0.051 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 8.890308e-01 | 0.051 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.890308e-01 | 0.051 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 8.890308e-01 | 0.051 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.890308e-01 | 0.051 | 0 | 0 |
| Common Pathway of Fibrin Clot Formation | R-HSA-140875 | 8.890308e-01 | 0.051 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 8.890308e-01 | 0.051 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 8.910976e-01 | 0.050 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.910976e-01 | 0.050 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.910976e-01 | 0.050 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 8.910976e-01 | 0.050 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 8.983799e-01 | 0.047 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 8.983799e-01 | 0.047 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 8.983799e-01 | 0.047 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.983799e-01 | 0.047 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 8.983799e-01 | 0.047 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.983799e-01 | 0.047 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 8.998346e-01 | 0.046 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.030169e-01 | 0.044 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.053237e-01 | 0.043 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.069418e-01 | 0.042 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.069418e-01 | 0.042 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.069418e-01 | 0.042 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.069418e-01 | 0.042 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.069418e-01 | 0.042 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.069418e-01 | 0.042 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.108803e-01 | 0.041 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 9.117667e-01 | 0.040 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.147829e-01 | 0.039 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 9.147829e-01 | 0.039 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.147829e-01 | 0.039 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.147829e-01 | 0.039 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 9.151629e-01 | 0.039 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.170149e-01 | 0.038 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.175444e-01 | 0.037 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 9.177967e-01 | 0.037 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.202854e-01 | 0.036 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.219636e-01 | 0.035 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.219636e-01 | 0.035 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.219636e-01 | 0.035 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.234375e-01 | 0.035 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.237714e-01 | 0.034 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.237714e-01 | 0.034 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.237714e-01 | 0.034 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 9.246684e-01 | 0.034 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.285397e-01 | 0.032 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.285397e-01 | 0.032 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.285397e-01 | 0.032 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.287118e-01 | 0.032 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 9.287118e-01 | 0.032 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.288625e-01 | 0.032 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.324823e-01 | 0.030 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.332040e-01 | 0.030 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.345620e-01 | 0.029 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.345620e-01 | 0.029 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.345620e-01 | 0.029 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.345620e-01 | 0.029 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.345790e-01 | 0.029 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.373000e-01 | 0.028 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 9.400771e-01 | 0.027 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.400771e-01 | 0.027 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.400771e-01 | 0.027 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.400771e-01 | 0.027 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.400771e-01 | 0.027 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.411628e-01 | 0.026 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 9.411628e-01 | 0.026 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.425476e-01 | 0.026 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.448040e-01 | 0.025 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.448040e-01 | 0.025 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.451276e-01 | 0.025 | 0 | 0 |
| Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane | R-HSA-83936 | 9.451276e-01 | 0.025 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.451276e-01 | 0.025 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.451276e-01 | 0.025 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.451276e-01 | 0.025 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.451276e-01 | 0.025 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 9.451276e-01 | 0.025 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.451276e-01 | 0.025 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.462617e-01 | 0.024 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.465625e-01 | 0.024 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.471315e-01 | 0.024 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.482349e-01 | 0.023 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 9.497528e-01 | 0.022 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.497528e-01 | 0.022 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.497528e-01 | 0.022 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.497528e-01 | 0.022 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.500563e-01 | 0.022 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.503091e-01 | 0.022 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.512269e-01 | 0.022 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.514662e-01 | 0.022 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.515020e-01 | 0.022 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 9.525897e-01 | 0.021 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.538041e-01 | 0.021 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.539884e-01 | 0.020 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.539884e-01 | 0.020 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.545085e-01 | 0.020 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 9.576658e-01 | 0.019 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 9.578671e-01 | 0.019 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.578671e-01 | 0.019 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.578671e-01 | 0.019 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.578671e-01 | 0.019 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.600653e-01 | 0.018 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 9.621332e-01 | 0.017 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.629328e-01 | 0.016 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 9.646719e-01 | 0.016 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.646719e-01 | 0.016 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.655706e-01 | 0.015 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.676505e-01 | 0.014 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.687757e-01 | 0.014 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.693199e-01 | 0.014 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.703782e-01 | 0.013 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.703782e-01 | 0.013 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.703782e-01 | 0.013 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.703782e-01 | 0.013 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.704376e-01 | 0.013 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.728761e-01 | 0.012 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.728761e-01 | 0.012 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.728761e-01 | 0.012 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.728761e-01 | 0.012 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.751634e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.751634e-01 | 0.011 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.751634e-01 | 0.011 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.762685e-01 | 0.010 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.772580e-01 | 0.010 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.772580e-01 | 0.010 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.779829e-01 | 0.010 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.779829e-01 | 0.010 | 0 | 0 |
| Ubiquinol biosynthesis | R-HSA-2142789 | 9.791761e-01 | 0.009 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.791761e-01 | 0.009 | 0 | 0 |
| Metabolism of folate and pterines | R-HSA-196757 | 9.791761e-01 | 0.009 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.795771e-01 | 0.009 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.804407e-01 | 0.009 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.804407e-01 | 0.009 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 9.805144e-01 | 0.009 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.809325e-01 | 0.008 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.810296e-01 | 0.008 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.810591e-01 | 0.008 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.820935e-01 | 0.008 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.840136e-01 | 0.007 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 9.840892e-01 | 0.007 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.842594e-01 | 0.007 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.842594e-01 | 0.007 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.842594e-01 | 0.007 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.849056e-01 | 0.007 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.852045e-01 | 0.006 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.865971e-01 | 0.006 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.870357e-01 | 0.006 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.887634e-01 | 0.005 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.888718e-01 | 0.005 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.895564e-01 | 0.005 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.897115e-01 | 0.004 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.897115e-01 | 0.004 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.897115e-01 | 0.004 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.904533e-01 | 0.004 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.917040e-01 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.918145e-01 | 0.004 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.918145e-01 | 0.004 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.927691e-01 | 0.003 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.927770e-01 | 0.003 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.933795e-01 | 0.003 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.935076e-01 | 0.003 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.936340e-01 | 0.003 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.936928e-01 | 0.003 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.939383e-01 | 0.003 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.941246e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.943703e-01 | 0.002 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.944500e-01 | 0.002 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.944500e-01 | 0.002 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.944500e-01 | 0.002 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.952414e-01 | 0.002 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.955982e-01 | 0.002 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.955982e-01 | 0.002 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.958812e-01 | 0.002 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.961000e-01 | 0.002 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.961000e-01 | 0.002 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.968120e-01 | 0.001 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.971324e-01 | 0.001 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.973329e-01 | 0.001 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.976181e-01 | 0.001 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.976647e-01 | 0.001 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.977031e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.977031e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.978280e-01 | 0.001 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.979372e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.981130e-01 | 0.001 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.985133e-01 | 0.001 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.986475e-01 | 0.001 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.988506e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.990499e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.990499e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.991302e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.991629e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.991629e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.992004e-01 | 0.000 | 1 | 1 |
| Transport of vitamins, nucleosides, and related molecules | R-HSA-425397 | 9.992710e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.992710e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.992867e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.992968e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.992968e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.993327e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.993417e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.993777e-01 | 0.000 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.993858e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.994490e-01 | 0.000 | 1 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.996987e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.997286e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.997539e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.997872e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.998582e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.998757e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.998857e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.998861e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999320e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999508e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999544e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999639e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999709e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999886e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999904e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999907e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999927e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999944e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999953e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999970e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999971e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 9.999975e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999977e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999980e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999986e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999987e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999987e-01 | 0.000 | 1 | 1 |
| O-linked glycosylation | R-HSA-5173105 | 9.999988e-01 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 9.999994e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999994e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999995e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999996e-01 | 0.000 | 1 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999997e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 1.000000e+00 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 1.000000e+00 | 0.000 | 1 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infection with Enterobacteria | R-HSA-9640148 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |